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A B S T R A C T
Background
Accurate diagnosis of tuberculosis in people living with HIV is diIicult. HIV-positive individuals have higher rates of extrapulmonary
tuberculosis and the diagnosis of tuberculosis is oKen limited to imaging results. Ultrasound is such an imaging test that is widely used
as a diagnostic tool (including point-of-care) in people suspected of having abdominal tuberculosis or disseminated tuberculosis with
abdominal involvement.
Objectives
To determine the diagnostic accuracy of abdominal ultrasound for detecting abdominal tuberculosis or disseminated tuberculosis with
abdominal involvement in HIV-positive individuals.
To investigate potential sources of heterogeneity in test accuracy, including clinical setting, ultrasound training level, and type of reference
standard.
Search methods
We searched for publications in any language up to 4 April 2019 in the following databases: MEDLINE, Embase, BIOSIS, Science Citation
Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Conference Proceedings Citation Index- Science (CPCI-S), and also
ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform to identify ongoing trials.
Selection criteria
We included cross-sectional, cohort, and diagnostic case-control studies (prospective and retrospective) that compared the result of the
index test (abdominal ultrasound) with one of the reference standards. We only included studies that allowed for extraction of numbers
of true positives (TPs), true negatives (TNs), false positives (FPs), and false negatives (FNs). Participants were HIV-positive individuals
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aged 15 years and older. A higher-quality reference standard was the bacteriological confirmation of Mycobacterium tuberculosis from any
clinical specimen, and a lower-quality reference standard was a clinical diagnosis of tuberculosis without microbiological confirmation.
We excluded genitourinary tuberculosis.
Data collection and analysis
For each study, two review authors independently extracted data using a standardized form. We assessed the quality of studies using a
tailored Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. We used the bivariate model to estimate pooled sensitivity
and specificity. When studies were few we simplified the bivariate model to separate univariate random-eIects logistic regression models
for sensitivity and specificity. We explored the influence of the type of reference standard on the accuracy estimates by conducting separate
analyses for each type of reference standard. We assessed the certainty of the evidence using the GRADE approach.
Main results
We included 11 studies. The risks of bias and concern about applicability were oKen high or unclear in all domains. We included six studies
in the main analyses of any abnormal finding on abdominal ultrasound; five studies reported only individual lesions.
The six studies of any abnormal finding were cross-sectional or cohort studies. Five of these (83%) were conducted in low- or middle-income
countries, and one in a high-income country. The proportion of participants on antiretroviral therapy was none (1 study), fewer then 50%
(4 studies), more than 50% (1 study), and not reported (5 studies). The first main analysis, studies using a higher-quality reference standard
(bacteriological confirmation), had a pooled sensitivity of 63% (95% confidence interval (CI) 43% to 79%; 5 studies, 368 participants; very
low-certainty evidence) and a pooled specificity of 68% (95% CI 42% to 87%; 5 studies, 511 participants; very low-certainty evidence). If
the results were to be applied to a hypothetical cohort of 1000 people with HIV where 200 (20%) have tuberculosis then:
- About 382 individuals would have an ultrasound result indicating tuberculosis; of these, 256 (67%) would be incorrectly classified as
having tuberculosis (false positives).
- Of the 618 individuals with a result indicating that tuberculosis is not present, 74 (12%) would be incorrectly classified as not having
tuberculosis (false negatives).
In the second main analysis involving studies using a lower-quality reference standard (clinical diagnosis), the pooled sensitivity was 68%
(95% CI 45% to 85%; 4 studies, 195 participants; very low-certainty evidence) and the pooled specificity was 73% (95% CI 41% to 91%; 4
studies, 202 participants; very low-certainty evidence).
Authors' conclusions
In HIV-positive individuals thought to have abdominal tuberculosis or disseminated tuberculosis with abdominal involvement, abdominal
ultrasound appears to have 63% sensitivity and 68% specificity when tuberculosis was bacteriologically confirmed. These estimates are
based on data that is limited, varied, and low-certainty.
The low sensitivity of abdominal ultrasound means clinicians should not use a negative test result to rule out the disease, but
rather consider the result in combination with other diagnostic strategies (including clinical signs, chest x-ray, lateral flow urine
lipoarabinomannan assay (LF-LAM), and Xpert MTB/RIF). Research incorporating the test into tuberculosis diagnostic algorithms will help
in delineating more precisely its value in diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement.
26 September 2019
Up to date
All studies incorporated from most recent search
All studies identified during the most recent search (4 Apr, 2019) have been incorporated in the review, and one ongoing study identified
P L A I N   L A N G U A G E   S U M M A R Y
Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in people
with HIV
Why is improving tuberculosis diagnosis in people with HIV important?
Diagnosing active tuberculosis in people living with HIV is challenging. People with advanced immunosuppression have high rates of
extrapulmonary tuberculosis (tuberculosis outside the lungs).
What is the aim of this review?
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The aim of this review is to find out how accurate an ultrasound examination of the abdomen (abdominal ultrasound) is for diagnosing
tuberculosis in people with HIV suspected of having tuberculosis in the abdomen or widespread tuberculosis (disseminated tuberculosis)
involving the abdomen.
What was studied in the review?
Abdominal ultrasound can be done aKer other tests (e.g. the chest x-ray did not indicate tuberculosis ) or it can be done before other tests
in people suspected of having tuberculosis. This review focuses on situations where other tests are not available.
What are the main results in this review?
We found 11 studies, but only six were relevant for the main analyses. The six studies were divided into two groups. In the first group
tuberculosis was diagnosed by identifying the organism causing tuberculosis from any specimen (microbiological confirmation). For the
second group, tuberculosis was diagnosed when healthcare personnel suspected tuberculosis and started anti-tuberculosis treatment,
but without identifying the organism (clinical diagnosis). Three studies provided results for both groups.
The review included five studies (a total of 879 participants) with microbiological confirmation. The results showed that if abdominal
ultrasound were to be used in a group of 1000 people with HIV where 200 (20%) have tuberculosis then:
- About 382 individuals would have an ultrasound result indicating tuberculosis; of these, 256 (67%) would be incorrectly classified as
having tuberculosis (false positives).
- Of the 618 individuals with a result indicating that tuberculosis is not present, 74 (12%) would be incorrectly classified as not having
tuberculosis (false negatives).
How reliable are the results of the studies in this review?
Microbiological confirmation is likely to be a reliable method for deciding whether people really have tuberculosis; clinical diagnosis is
likely to be less trustworthy. We found problems in both groups with how studies were conducted. Decreasing the number of false positive
results may make abdominal ultrasound appear more accurate than it is. Numbers shown are an average across studies. As estimates from
individual studies varied, we cannot be sure that abdominal ultrasound will always produce these results. Not enough people have been
studied for us to be confident about the results.
Who do the results of the review apply to?
Studies included in the main analyses were done in Cambodia, India, South Africa, South Sudan, Spain, and Tanzania. Reasons for including
people diIered between the studies. Four studies used trained radiologists (specialists) or sonographers; two used doctors trained in
ultrasound (non-specialists), and two included people without any suspicion of tuberculosis. Across the studies, the percentage of people
with a final diagnosis of tuberculosis ranged from 18% to 64%.
What are the implications of this review?
If the test is used to rule in the disease in the absence of other evidence, then, the chance of diagnosing someone with tuberculosis when
they actually do not have it is high. Chances of missing a diagnosis of tuberculosis when the test is positive are lower, but a negative test
alone is probably insuIicient to rule out the disease. These findings should be considered when deciding whether or not to use abdominal
ultrasound to test for tuberculosis involving the abdomen and how to interpret the results in the context of other clinical and diagnostic
test information.
How up-to-date is this review?
The review authors searched for studies up to 4 April 2019.
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S U M M A R Y   O F   F I N D I N G S
 
Summary of findings 1.   Summary of findings for abdominal ultrasound (any abnormality)
Review question: Should abdominal ultrasound be used to diagnose abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV-positive in-
dividuals?
Patient or population: HIV-positive individuals
Setting: Healthcare facility
Index test: Abdominal ultrasound
Reference standard: We considered two reference standards. The higher-quality reference standard was bacteriological confirmation of M tuberculosis (any clinical speci-
men including (i) at least one specimen culture positive for M tuberculosis, (ii) microscopic identification of acid-fast bacilli on stained sputum smears, lymph node aspirate,
or any other specimen; or iii) Xpert MTB/RIF positive). The lower-quality reference standard was clinical diagnosis of TB without microbiological confirmation (including cas-
es diagnosed on the basis of: i) suggestive histology (necrotizing granulomatous inflammation), ii) x-ray abnormalities, iii) extrapulmonary cases without laboratory confir-
mation, and iv) anti-tuberculosis therapy initiated by a healthcare practitioner for cases with a high suspicion of tuberculosis).
Threshold: Any abnormality found on abdominal ultrasound
Study design: Cross-sectional and cohort
Limitations: A small number of studies and participants were included in the analyses. Risks of bias were generally high in the patient selection domain
Number of results per 1000 HIV-positive individuals tested
(95% CI)
Test result











Bacteriological confirmation as reference standard: pooled sensitivity = 63% (95% CI 43% to 79%) and pooled specificity = 68% (95% CI 42% to 87%)
True positives (participants correctly classified as having tuber-
culosis)
63 (43 to 79) 126 (86 to 158) 252 (172 to 316)
False negatives (participants incorrectly classified as not having
tuberculosis)




True negatives (participants correctly classified as not having
tuberculosis)
612 (378 to 783) 544 (336 to 696) 408 (252 to 522)
False positives (participants incorrectly classified as having tu-
berculosis)
























































































































































































































GRADE certainty of evidence (GRADEpro GDT 2015; Schünemann 2016)
High certainty: We are very confident that the true eIect lies close to that of the estimate of the eIect.
Moderate certainty: We are moderately confident in the eIect estimate: The true eIect is likely to be close to the estimate of the eIect, but there is a possibility that it is
substantially diIerent.
Low certainty: Our confidence in the eIect estimate is limited: The true eIect may be substantially diIerent from the estimate of the eIect.
Very low certainty: We have very little confidence in the eIect estimate: The true eIect is likely to be substantially diIerent from the estimate of eIect.
The table displays normalized frequencies within a hypothetical cohort of 1000 people at three diIerent tuberculosis prevalences (pre-test probabilities): 10%, 20% and 40%. We
selected prevalence values based on the range of prevalence observed across the included studies. We estimated confidence intervals based on those around the point estimates
for pooled sensitivity and specificity.
Explanations
aRisk of bias: We rated one study at high risk for participant selection since it excluded people unable to produce sputum (Griesel 2019-h). We downgraded the certainty of the
evidence by one level.
bIndirectness: We deemed three studies to be of high concern for applicability for receiving ultrasound in a tertiary care (referral) centre (Ndege 2019-h; Sculier 2010-h Weber
2018-h). Two studies only included asymptomatic HIV-positive participants (Bobbio 2019-l; Sculier 2010-h). We downgraded the certainty of the evidence by two levels.
cInconsistency: Point estimates were substantially diIerent between studies. We could not explain this variability and we downgraded the certainty of the evidence by one level.
dImprecision:Three studies had a wide 95% CI for true positives and false negatives (Dominguez-Castellano 1998-h; Sculier 2010-h; Weber 2018-h). We downgraded the certainty
of the evidence by one level.
eRisk of bias: All studies used a higher-quality reference standard. We did not downgrade the certainty of the evidence.
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B A C K G R O U N D
Target condition being diagnosed
Tuberculosis is caused by the bacillus Mycobacterium tuberculosis.
Although it usually aIects the lungs (pulmonary tuberculosis), it
can also spread to other body sites (extrapulmonary tuberculosis)
(WHO 2018).
An estimated 10 million people were diagnosed with tuberculosis
in 2017, and 1.6 million people died from tuberculosis (WHO 2018).
Resource-limited countries are the most aIected; for example, the
African region of the World Health Organization (WHO) had the
second highest estimated number of incident cases (2.5 million),
but the highest incidence rate (237 versus 133 globally) and
mortality rate (HIV-positive: 24 versus 4.0 globally; HIV-negative: 39
versus 17 globally) per 100,000 people (WHO 2018).
The probability of developing tuberculosis is higher among
people living with HIV. Approximately 920,000 people diagnosed
worldwide with tuberculosis in 2017 were HIV-positive (WHO 2018),
with HIV prevalence among incident tuberculosis cases in the
African region at 27% (WHO 2018).
The worldwide case detection rate in 2016 was only an estimated
61% (WHO 2017), reflecting a mixture of under-reporting of
detected cases and underdiagnosis of tuberculosis. The low
detection rate possibly relates to delays in diagnosis, which could
be from problems with tuberculosis diagnostic tests (accuracy
and availability), the negative influence of HIV infection on the
performance of diagnostic tests, and HIV co-infection and the
opportunistic conditions that complicate it (Palmieri 2002; Dawson
2010; Padmapriyadarsini 2011; Horne 2019; WHO 2017). Other
factors might be weaknesses in health systems and broader
social and economic influences (for example, undernourishment,
poverty) on the tuberculosis epidemic (WHO 2017). The diagnosis
of active tuberculosis in HIV-positive people with advanced
immunosuppression is challenging due to more atypical clinical
presentations; other opportunistic pulmonary infections with
similar presentations; a high proportion of negative sputum
smears; and high rates of extrapulmonary tuberculosis (Sharma
2005). This is illustrated by autopsy studies, which indicate a
very high proportion of tuberculosis in HIV-positive adults (32%
to 47%); almost half (46%) of adult tuberculosis cases remained
undiagnosed before death (Gupta 2015).
An estimated 14% of the 6.4 million incident tuberculosis cases
in 2017 were extrapulmonary tuberculosis (WHO 2018). In people
with HIV-associated tuberculosis, extrapulmonary tuberculosis
accounts for up to 50% of all tuberculosis cases (Sharma 2004b;
Kingkaew 2009; Namme 2013), and is oKen disseminated (two
or more non-contiguous sites simultaneously infected) (Sharma
2005). Any anatomical site can be involved, but the commonest
sites are the lymph nodes, pleura, meninges, and the abdominal
cavity (Sharma 2005). Many terms are used in the literature to
describe tuberculosis in the abdominal cavity. For the purposes of
this Cochrane Review, we use the terms abdominal tuberculosis or
disseminated tuberculosis with abdominal involvement, excluding
genitourinary tuberculosis. Many abdominal structures can be
aIected in abdominal tuberculosis or disseminated tuberculosis
with abdominal involvement, including involvement of the
gastrointestinal tract, peritoneum, omentum, mesentery, intra-
abdominal lymph nodes, and solid organs (liver, spleen, pancreas)
(Sharma 2004b). People oKen present with non-specific symptoms
and signs, and a high index of suspicion is therefore needed
for early diagnosis and timely management. It mimics a large
number of medical and surgical conditions, including malignant
neoplasms, inflammatory bowel disease, chronic liver disease, and
other gastrointestinal infections (Jadvar 1997).
Index test(s)
Many HIV-positive people with low CD4 counts have abdominal
tuberculosis or disseminated tuberculosis with abdominal
involvement. As sputum smears are frequently negative in HIV-
associated tuberculosis, it is common clinical practice, supported
by WHO guidelines, to reach a tuberculosis diagnosis on the basis
of imaging results and clinical case definitions (Wilson 2006; WHO
2016). Ultrasound is such an imaging test that can be used as a
diagnostic tool (Heller 2010a; Heller 2010b; Patel 2011; Giordani
2013; Sharma 2017), although the only WHO recommendation
refers to the use of ultrasound to diagnose pericardial eIusions
(WHO 2006). Ultrasound uses sound waves to produce images
of structures and organs within the body, and has traditionally
been performed by trained specialists in dedicated radiology
departments. However, the numerous advantages of ultrasound
(e.g. rapidly performed, portable, non-invasive, repeatable, etc.)
have led to many physicians in diIerent specialties adopting
ultrasound (Adhikari 2014). The use of ultrasound by trained
medical professionals (non-radiologists) is particularly relevant in
resource-limited settings. Computed tomography (CT) or magnetic
resonance imaging (MRI) is expensive, mostly only available in
tertiary-level settings, and require specially-trained personnel to
perform and report these examinations. Many low-income and
middle-income countries have a high tuberculosis burden (WHO
2018), but without widespread access to specialists and tertiary-
level imaging. However, ultrasound machines are mostly accessible
and their use by non-radiologists would be of great value.
Abdominal ultrasound (an ultrasound examination evaluating the
abdominal cavity) may be useful in HIV-positive people with
suspected abdominal tuberculosis or disseminated tuberculosis
with abdominal involvement. Ultrasound techniques to diagnosis
HIV-associated tuberculosis are easily learned by non-radiologists
and quick to perform (less than 10 minutes) (Heller 2010a).
The ultrasound findings are non-specific, and various other
diseases may present with the same features. For example, intra-
abdominal lymphadenopathy can be due to other infections
(for example, cryptococcosis, histoplasmosis); lymphomas (non-
Hodgkin's lymphoma and Hodgkin's lymphoma); and Kaposi's
sarcoma (Martin-Bates 1993).
Clinical pathway
Any structure or organ in the abdominal cavity (for example,
gastrointestinal tract, pancreatobiliary system, peritoneum, and
lymph nodes) can be aIected by tuberculosis disease. The
presentation varies considerably and depends on the specific
organ involved (Sharma 2017); other diseases are also oKen
mimicked (Sharma 2004a). Common presenting symptoms are
abdominal pain, anorexia, bowel disturbances, fever, and weight
loss. The clinical examination oKen reveals abdominal tenderness,
ascites, and solid organ enlargement (for example, hepatomegaly,
splenomegaly, or hepatosplenomegaly) (Ibrahim 2005; Mandal
2011; Sharma 2017).
Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV-positive
individuals (Review)










Cochrane Database of Systematic Reviews
Essential diagnostic tests for individuals who are suspected of
having abdominal tuberculosis or disseminated tuberculosis with
abdominal involvement include a chest x-ray, sputum evaluation
(if able to produce) for bacteriological confirmation of tuberculosis
disease (smear or culture or Xpert MTB/RIF), and blood cultures
(WHO 2013b). Urine specimens remain a convenient clinical
sample for the diagnosis of tuberculosis. Although conventional
tuberculosis diagnostics applied to urine specimens have limited
clinical utility, the use of urinary lipoarabinomannan (LAM) has
been recommended by the WHO in HIV-positive adults with
advanced immunosuppression (CD4 cell count of 100 cells/µL or
less) or in HIV-positive adults who are seriously ill (respiratory rate
above 30/min, temperature above 39 °C, heart rate above 120/min
and unable to walk unaided), regardless of their CD4 cell count
(WHO 2015; Shah 2016). These tests are usually done in the primary
care setting and higher.
Abdominal ultrasound has become part of the initial diagnostic
work-up in adults living with HIV where abdominal tuberculosis
or disseminated tuberculosis with abdominal involvement is
suspected (especially in those with a low CD4 count), despite the
lack of robust evidence of validity from large studies (NICE 2016).
The diagnostic pathway might vary in diIerent settings if there are
ultrasound findings suggestive of tuberculosis. In resource-limited
settings this might be enough evidence to initiate anti-tuberculosis
treatment, but in high-resource settings it would prompt site-
specific investigations which could include CT scan, paracentesis,
laparoscopy, fine needle aspiration, or stool examination.
A presumptive diagnosis of abdominal tuberculosis or
disseminated tuberculosis with abdominal involvement can be
made in the setting of known active pulmonary tuberculosis,
although fewer than half of chest radiographs are compatible
with active or healed tuberculosis (Chow 2002). However, data are
lacking in HIV-positive individuals.
WHO recommends immediate initiation of anti-tuberculosis
therapy in people living with HIV who have clinical features
of disseminated tuberculosis (WHO 2016). Bacteriological
confirmation of tuberculosis from any specimen remains
important, but treatment should not be delayed until results
become available (Figure 1). People started on anti-tuberculosis
therapy without bacteriological confirmation should be assessed
aKer one month to evaluate the clinical response to treatment.
They should be re-assessed and an alternative diagnosis sought if
there is no clinical improvement.
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Figure 1.   Diagnostic workup of HIV-positive individuals with suspected abdominal tuberculosis or disseminated
tuberculosis with abdominal involvement
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Role of index test(s)
Abdominal ultrasound is oKen combined with existing tests
such as chest x-ray, haemoglobin, etc. to reach a diagnosis
of abdominal tuberculosis or disseminated tuberculosis with
abdominal involvement in clinical practice. However, all the
existing tests that could inform a confirmed diagnosis may not
always be available.
Alternative test(s)
Ascitic fluid analysis suggestive of abdominal tuberculosis or
disseminated tuberculosis with abdominal involvement includes
a leukocyte count of 150 to 4000 cells/mL, which consists
predominantly of lymphocytes (Sharma 2004a; Sanai 2005). The
ascitic fluid is usually an exudate with the protein content greater
than 30 g/L and the serum-ascites albumin gradient (SAAG) less
than 11 g/L (Sharma 2004a; Sanai 2005). Adenosine deaminase
activity (ADA) of ascitic fluid (> 39 IU/L) is also suggestive of
abdominal tuberculosis (Riquelme 2006), while the ascites to
blood glucose ratio is usually less than 0.96 (Wilkins 1984). Acid-
fast bacilli (AFB) smear and culture of ascitic fluid also have
disappointingly low yields (Chow 2003), while Xpert MTB/RIF
for peritoneal tuberculosis using peritoneal fluid has a pooled
sensitivity of 59% (credible interval (CrI) 45 to 74) and a pooled
specificity of 98% (CrI 96 to 99) (Kohli 2018).
DiIerent imaging modalities can be useful to diagnose abdominal
tuberculosis or disseminated tuberculosis with abdominal
involvement. Abdominal x-rays are of very limited value, but can
assist with the diagnosis of intestinal obstruction and perforation
(Debi 2014). CT features include thickening of the peritoneum,
omentum, and bowel wall; lymph nodes (especially if these have
hypodense centres due to caseous necrosis); and ascites with
strands, debris, and fine septations (Sharma 2004a; Lee 2012).
The excellent soK tissue resolution and multiplanar acquisition of
MRI have resulted in it being used to evaluate solid organs and
lymphadenopathy (Joshi 2014). However, CT and especially MRI are
expensive and access is very limited in resource-limited settings.
Barium studies may be useful for intrinsic bowel abnormalities
such as strictures, fistulae, and erosions (Sharma 2004a; Debi 2014).
Colonoscopy with biopsy is a useful non-operative diagnostic
procedure to obtain material for histology and culture (Kim 1998).
Mucosal nodules and transverse ulcers in the bowel are very
suggestive of tuberculosis, with definitive results obtained from
tissue sent for polymerase chain reaction (PCR), Ziehl-Neelsen
stain, and culture (Kim 1998; Sharma 2004a). Laparoscopy is useful
in two ways: (i) it allows visual inspection of the peritoneum;
and (ii) it permits specimens for histology, AFB stain, and culture
to be obtained. However, imaging modalities as described above
provide a safer, less invasive and less expensive alternative, but
may be less specific since they are unable to provide a definitive
microbiological diagnosis (Sanai 2005).
Most studies relating to the diagnosis of tuberculosis were done
in HIV-negative people and the true diagnostic accuracy of the
above tests in those living with HIV remains uncertain. Expanded
clinical case definitions were developed to diagnose smear-
negative tuberculosis in HIV-positive people living in resource-
limited settings (Wilson 2006), including abdominal tuberculosis
or disseminated tuberculosis with abdominal involvement (Wilson
2006; WHO 2016). For example, a person presenting with symptoms
and signs suggestive of abdominal tuberculosis or disseminated
tuberculosis with abdominal involvement can be started on anti-
tuberculosis treatment if the ascitic fluid consists of a lymphocytic
exudate along with either a fever of 38 °C or more on two occasions
or drenching sweats for more than two weeks (Wilson 2006). In
this study, the positive predictive value for abdominal lymph nodes
diagnosed by ultrasound was 94% (Wilson 2006). Augmented by the
use of objective criteria to monitor response to treatment within
the first eight weeks, this approach has reasonable diagnostic
accuracy (Wilson 2006).
Rationale
Multiple studies of various quality and designs have looked
at the use of abdominal ultrasound as a diagnostic tool
for abdominal tuberculosis or disseminated tuberculosis with
abdominal involvement, with varying sensitivity, specificity, and
predictive values for diagnosing tuberculosis (Monill-Serra 1997-l;
Mugala 2006; Sinkala 2009-l; Sculier 2010-h; Patel 2011). Abdominal
ultrasound may be used alone, in combination with existing tests
(chest radiograph, full blood count), or as an add-on following
negative results from existing tests (smear microscopy, sputum
Xpert MTB/RIF, sputum culture, chest radiograph). The role of
abdominal ultrasound as an add-on test is an important clinical
question because it may reflect the way that abdominal ultrasound
is used in practice, especially in resource-limited settings. However,
aKer a scoping search, we did not find any studies that have
evaluated the accuracy of ultrasound as an add-on test or in
combination with other tests.
O B J E C T I V E S
To determine the diagnostic accuracy of abdominal ultrasound
for detecting abdominal tuberculosis or disseminated tuberculosis
with abdominal involvement in HIV-positive individuals.
Secondary objectives
To investigate potential sources of heterogeneity in test accuracy,
including clinical setting, ultrasound training level, and type of
reference standard.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included cross-sectional, cohort, or diagnostic case-control
studies (prospective and retrospective) that compared the result
of the index test (abdominal ultrasound) with one of the reference
standards (see Reference standards). Case-control studies may
overestimate sensitivity and specificity, but we include them
because we anticipated identifying few relevant studies. We only
included studies in which the study authors reported the numbers
of true positives (TPs), true negatives (TNs), false positives (FPs),
and false negatives (FNs), or where we were able to derive the data
from reported statistics. We also wrote to all study authors where
data were missing. We excluded descriptive studies (for example,
case series).
Participants
We included all HIV-positive individuals (aged 15 years and
older) with a clinical suspicion of abdominal tuberculosis or
disseminated tuberculosis with abdominal involvement (excluding
Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV-positive
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genitourinary tuberculosis), who were investigated using an
abdominal ultrasound examination. We also considered studies
that included confirmed cases of abdominal tuberculosis and
controls. We did not place any restrictions on setting. Although
abdominal ultrasound can be used to evaluate children,
microbiological confirmation of tuberculosis is far more diIicult
than in adults, and so we excluded children where possible.
Index tests
We included studies that evaluated the accuracy of abdominal
ultrasound. We did not place any restrictions on the type of
ultrasound machine used or the qualification of the person
performing the ultrasound, but recorded these data. A positive
result was an ultrasound scan with abnormal findings suggestive
of abdominal tuberculosis or disseminated tuberculosis with
abdominal involvement, including, but not limited to, free
abdominal fluid, abdominal lymph nodes, hepatic lesions, and
splenic lesions. A negative result was an ultrasound scan with no
abnormal findings.
Target conditions
Active disease due to M tuberculosis – either abdominal
tuberculosis or disseminated tuberculosis with abdominal
involvement.
Reference standards
We used a hierarchy of reference standards. The reference standard
diagnosis typically relates to microbiological confirmation
(microscopy or culture), although histopathological characteristics
strongly support a diagnosis of active tuberculosis in clinically
and epidemiologically appropriate settings. Xpert MTB/RIF assay
(an automated nucleic acid amplification test) can also identify
M tuberculosis. A clinical diagnosis of tuberculosis is sometimes
used in the absence of confirmative tests, for example, probable
tuberculosis can be defined as the clinical picture of tuberculosis
without objective diagnostic tuberculosis criteria and treated for
tuberculosis by the attending physician. Although this approach is
clinically useful, it is very subjective as it relies on the clinical gestalt
of the treating physician. We therefore viewed it as a lower-quality
reference standard.
The primary (higher-quality) reference standard was
bacteriological confirmation of any clinical specimen including
(i) at least one specimen culture positive for M tuberculosis, (ii)
microscopic identification of AFB on stained sputum smears, lymph
node aspirate, or any other specimen; or iii) Xpert MTB/RIF positive
(WHO 2013a). We considered a positive result on any of these
tests as a positive result for the microbiological (higher-quality)
reference standard and a tuberculosis case, since not all of the
tests might have been performed or might have a positive result.
The reference standard for culture was either solid or liquid
culture for M tuberculosis complex (Lawn 2011). The sensitivity of
smear microscopy can be increased by examining more than one
sample, using fluorescence microscopy, and using physical and
chemical sputum processing techniques including centrifugation,
sedimentation, and bleach (Steingart 2006a; Steingart 2006b). We
therefore included studies that used any of these techniques.
The secondary (lower-quality) reference standard was clinical
diagnosis of tuberculosis without microbiological confirmation.
A clinically diagnosed tuberculosis case is one that has been
diagnosed with active tuberculosis by a healthcare practitioner
and where anti-tuberculosis therapy has subsequently been
initiated. This definition lacks bacteriological confirmation but
includes cases diagnosed on the basis of suggestive histology
(necrotizing granulomatous inflammation), x-ray abnormalities,
and extrapulmonary cases without laboratory confirmation (WHO
2017). Using clinical diagnosis as a reference standard could
potentially bias test accuracy because abdominal ultrasound is
oKen used to inform the clinical decision to treat for tuberculosis
(incorporation bias). We included these studies, as incorporation
bias had a small eIect in diagnostic accuracy estimates (Rutjes
2006), and we used an adapted version of the revised tool for the
Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2).
Search methods for identification of studies
Electronic searches
Vittoria Lutje (VL), the Information Specialist for the Cochrane
Infectious Diseases Group (CIDG), performed literature searches
up to 4 April 2019, without language restrictions. She searched
MEDLINE (PubMed, 1946 to 4 April 2019); Embase (Ovid, 1947 to 4
April 2019); Biosis (Web of Science, 1926 to 4 April 2019); Science
Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation
Index (SSCI), both 1900 to 4 April 2019, and Conference Proceedings
Citation Index- Science (CPCI-S), 1990 to 4 April 2019, (all three
in the Web of Science). She also searched ClinicalTrials.gov and
the WHO International Clinical Trials Registry Platform (ICTRP;
apps.who.int/trialsearch/) for trials in progress. The search terms
and strategy are reported in Appendix 1.
Searching other resources
We examined the reference lists of relevant reviews and studies;
and searched websites of the WHO, the Stop TB Partnership, and
the National Institute of Allergy and Infectious Diseases (NIAID).
We also performed forward citation searching of relevant articles
using the PubMed ‘related articles' feature, Google Scholar, and
ISI citation indices. We also contacted study authors for additional
information if we deemed it necessary.
Data collection and analysis
Selection of studies
Two review authors (DJvH and RG) independently judged study
eligibility by examining the title and abstract of each article
identified by the literature search and excluded obviously irrelevant
studies. We obtained the full-text article if either review author
considered the abstract to be potentially eligible. The two review
authors independently assessed each full-text article against the
predefined inclusion and exclusion criteria, as stated in the ‘Criteria
for considering studies for this review' section. The two review
authors resolved any disagreements by discussion. If the review
authors could not reach consensus, a third review author (GrM)
made the final decision. We maintained a list of all articles excluded
aKer full-text assessment and their reasons for exclusion in the
‘Characteristics of excluded studies' table. The study selection
process is also illustrated using a PRISMA flow diagram.
Data extraction and management
We developed a standardized data extraction form before two
review authors (DJvH and RG) independently extracted data. The
extracted data were:
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1. Details of study: first author, publication year, journal, study
design, inclusion/exclusion criteria
2. Characteristics of study population: age, gender, estimated
tuberculosis prevalence in study setting; estimated HIV
prevalence in study setting, antiretroviral therapy (ART) status
3. Reference standard: bacteriological, clinical
4. Index test: general (abdominal ultrasound normal or abnormal),
specific (individual findings on ultrasound), training level of
person performing the ultrasound, additional tests (and their
results)
5. Details of outcome: number of indeterminate, missing or
unavailable test results, number of TP, TN, FP, and FN results
We resolved any discrepancies in data extraction by discussion, and
a third review author (GrM) had the final say.
Assessment of methodological quality
We used the revised tool for the Quality Assessment of Diagnostic
Accuracy Studies (QUADAS-2) to assess the risks of bias and
applicability of included studies (Whiting 2011). We tailored
the tool to the context of the review, as shown in Appendix
2. Two review authors (DJvH and RG) independently assessed
methodological quality using the tailored QUADAS-2 tool. We
resolved any disagreements through consensus or by consulting a
third review author (EAO). We present the results in graphs, text,
and the ‘Characteristics of included studies' table.
Statistical analysis and data synthesis
In our primary meta-analyses, we used the individual participant
as the unit of analysis (that is, any abnormal finding versus none)
and not individual ultrasound findings. Clinically, it is also useful
to know the accuracy of individual ultrasound findings, as it is
plausible that some findings are better indicators of tuberculosis
than others. We therefore determined the accuracy of individual
ultrasound findings in secondary analyses.
We only included studies that reported test thresholds to enable us
to construct 2 x 2 tables and also to select an appropriate method
of meta-analysis. Studies used diIerent criteria to determine
the positivity of ultrasound. For example, studies may define
an ultrasound scan as positive based on the presence of any
abnormal abdominal finding including (but not limited to) organ
enlargement, the presence or number of hepatic or splenic lesions,
or the presence or size of abdominal nodes. For the primary
analysis we thus defined the threshold as the presence or absence
of any abnormal lesion. In order to produce clinically meaningful
results, we conducted two separate sets of primary meta-analyses
by estimating the pooled sensitivity and specificity for each type of
reference standard (higher quality and lower quality).
For the secondary analyses (individual lesion as unit of analysis),
we did not estimate the pooled sensitivity and specificity because
some studies did not report thresholds and those that did used
diIerent thresholds. We only report the range of sensitivity and
specificity.
We used the number of TPs, FPs, FNs, and TNs to construct 2 x
2 tables using the criteria specified in the studies. We plotted the
estimates of sensitivity and specificity from the included studies
on forest plots using Review Manager 5 soKware (Review Manager
2014).
We used the bivariate model (Chu 2006) to estimate pooled
sensitivity and specificity at common thresholds. We fitted the
models using the xtmelogit command in Stata version 15.0
(StataCorp, College Station, TX, USA).
Investigations of heterogeneity
Potential sources of heterogeneity included the type of reference
standard (higher quality versus lower quality), clinical setting (any
setting versus tertiary/referral hospital), and ultrasound training
level (radiologist versus non-radiologist). We stratified the primary
analysis by the type of reference standard. Due to the small number
of included studies and sample sizes we did not investigate other
sources of heterogeneity.
Sensitivity analyses
We did not perform sensitivity analyses because of the small
number of included studies.
Assessment of reporting bias
We did not carry out a formal assessment of publication bias.
Assessment of the certainty of the evidence
We used the GRADE approach (Schünemann 2016) and GRADEpro
Guideline Development Tool (GDT) soKware (GRADEpro GDT 2015)
to assess the certainty of the evidence (also called the quality of
the evidence). We rated the certainty of the evidence as either
high (not downgraded), moderate (downgraded by one level),
low (downgraded by two levels), or very low (downgraded by
more than two levels) for five domains: risk of bias, indirectness,
inconsistency, imprecision, and publication bias. For each domain,
the certainty of evidence started as high if there were high-
quality observational studies (cross-sectional or cohort studies)
that enrolled participants with diagnostic uncertainty. We used our
judgement to classify the reason for downgrading as either serious
(downgraded by one level) or very serious (downgraded by two
levels).
Two review authors (DJvH and RG) discussed judgements and
applied GRADE in the following way.
Risk of bias: we used the tailored QUADAS-2 to assess risks of bias.
Indirectness: we used the tailored QUADAS-2 for concerns of
applicability and evaluated the studies for important diIerences
between the populations studied (for example, age) and the setting.
We made judgements on whether the diIerences were suIicient to
lower our certainty in the results.
Inconsistency: we downgraded the certainty of the evidence for
unexplained inconsistency in sensitivity and specificity estimates.
Imprecision: we considered a point estimate to be substantially
diIerent if it would alter a clinical decision. We considered the
width of the CI, and whether a diIerent clinical decision would be
made if the lower or upper boundary of the CI represented the
truth. We also made judgements on the imprecision of projected
ranges for TP, FN, TN, and FP for a given prevalence of tuberculosis.
Publication bias: as recommended, we did not downgrade the
certainty of evidence for publication bias for the following reasons
(Schünemann in press). We did not detect studies done for-profit
interest. Included studies had small sample sizes and accuracy
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estimates were low and imprecise. We did an extensive search
in electronic databases and grey literature and did not identify
completed studies that were unpublished. We only identified one
ongoing study, the results of which are not yet registered in the Pan
African Clinical Trials Registry (Trial ID: PACTR201712002829221)
(PACTR201712002829221).
R E S U L T S
Results of the search
Our search yielded 1129 records. We identified two additional
studies through contact with experts. AKer we removed one
duplicate, we had 1130 records. We excluded 1089 records based on
a review of title, abstract, or both. We retrieved 41 full-text articles
and excluded 30 studies for the following reasons: descriptive
study (22 studies); ineligible participant population (2 studies);
no reference standard reported (2 studies); ineligible index test
evaluated (1 study); only abnormal index test reported (2 studies);
and not a diagnostic accuracy study (1 study). We therefore include
11 unique studies in this review (Barreiros 2008-h; Bobbio 2019-
l; Dominguez-Castellano 1998-h; Griesel 2019-h; Kaneria 2009-l;
Monill-Serra 1997-l; Ndege 2019-h; O'Keefe 1998-h; Sculier 2010-h;
Sinkala 2009-l; Weber 2018-h). We listed the excluded studies and
reasons for their exclusion in the Characteristics of excluded studies
section. Figure 2 shows the flow of studies through the screening
process.
 
Figure 2.   Study flow diagram.
 
Three studies were conducted in low-income countries, three
in lower-middle-income countries, two in upper-middle-income
countries, and three in high-income countries. We noted poor
reporting on the estimated prevalence of tuberculosis and HIV
in study setting, qualification of sonographer and setting in
which ultrasound was performed. Studies used diIerent criteria
to determine the positivity of ultrasound (see Characteristics of
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included studies section). Key findings of included studies are
presented in Table 1 and Table 2.
We contacted the authors of all 11 studies, of whom five responded.
We received unpublished data from four studies (Weber 2018-
h; Bobbio 2019-l; Griesel 2019-h; Ndege 2019-h), and one study
clarified the qualification of the sonographer (O'Keefe 1998-h).
Methodological quality of included studies
We present the results of the methodological assessment of the 11
studies in Figure 3. The results are reported below separately for
studies included in the primary analyses (any abnormal finding)
and those included in the secondary analyses (individual lesions).
Studies that used a higher-quality reference standard are indicated
with the suIix ‘h' and studies that used a lower-quality reference
standard are indicated with the suIix ‘l'.
 
Figure 3.   Risk of bias and applicability concerns summary: review authors' judgements about each domain for each
included study. SuHix (h) indicates higher quality reference standard; suHix (l) indicates lower quality reference
standard.
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Studies of any abnormal finding included in primary analyses
Six studies with a higher-level reference standard contributed data
(Figure 3). One study was considered to be at high risk of bias
in the patient selection domain since it excluded people unable
to produce sputum (Griesel 2019-h). Concerns about applicability
(i.e. are there concerns that the included participants do not
match the review question?) were deemed high in four studies,
since they included asymptomatic people (Sculier 2010-h; Bobbio
2019-l) or were conducted in a referral or tertiary setting (Sculier
2010-h; Weber 2018-h; Bobbio 2019-l; Ndege 2019-h). One study
was deemed of unclear concern as the setting in which the
ultrasound was done was not reported (Dominguez-Castellano
1998-h). In the index test domain, we considered one study to be
at unclear risk of bias because, although the study did specify
thresholds for positivity, the test was sometimes interpreted with
knowledge of the results of the reference standard (Weber 2018-
h). We considered the conduct and interpretation of the index test
to be of high concern for applicability in one study where the
ultrasound was performed by a trained radiologist (Sculier 2010-h).
In the reference standard domain, all studies used a higher-quality
reference standard (microbiological confirmation). We regarded
two studies as being of high concern for applicability, as neither
study speciated mycobacteria isolated in culture (Sculier 2010-h;
Weber 2018-h). For the flow and timing domain, we considered one
study to be at unclear risk of bias because the study did not report
the interval between the index test and the reference standard,
and it was unclear if all participants received the same reference
standard (Dominguez-Castellano 1998-h).
For the main analyses (abnormal versus normal ultrasound
examination), four studies with a lower-level reference standard
contributed data (Figure 3). We considered one study to be at high
risk of bias in the patient selection domain because it did not enrol
participants consecutively or randomly (Bobbio 2019-l). Concerns
about applicability (i.e. are there concerns that the included
participants do not match the review question?) were deemed high
in three studies since they included asymptomatic participants
(Bobbio 2019-l), or the study was conducted in a referral or tertiary
setting (Weber 2018-l; Bobbio 2019-l; Ndege 2019-l). We rated one
study at unclear concern as the setting in which the ultrasound was
done was not reported (Dominguez-Castellano 1998-l). In the index
test domain, we considered one study to be at unclear risk of bias
because the index test was sometimes interpreted with knowledge
of the results of the reference standard (Weber 2018-l). In the
reference standard domain, we considered all studies to be at high
risk of bias because the studies included a lower-quality reference
standard (clinical diagnosis) ( Dominguez-Castellano 1998-l; Weber
2018-l; Bobbio 2019-l; Ndege 2019-l). We rated one study at unclear
concern for applicability since it is unclear whether all clinically
diagnosed participants improved on anti-tuberculosis treatment
(Weber 2018-l). In terms of the flow and timing domain, we
considered one study to be at unclear risk of bias because the study
did not report the interval between the index test and the reference
standard, and it was unclear if all participants received the same
reference standard (Dominguez-Castellano 1998-l). We judged one
study to be at high risk of bias because not all participants received
a reference standard and not all participants received the same
reference standard (Bobbio 2019-l).
Studies of individual lesions included in secondary analyses
Nine studies contributed data (Figure 3). In the patient selection
domain, we deemed five studies (56%) to be at high risk of bias
because: i) three studies used a case-control design (Monill-Serra
1997-l; Barreiros 2008-h Kaneria 2009-l); ii) one study excluded
patients with a CD4 cell count of 200 or more (O'Keefe 1998-h);
and iii) one study excluded patients unable to produce sputum
(Griesel 2019-h). For applicability, we judged four studies (44%)
to be at high concern since one study included HIV-negative
participants (Barreiros 2008-h), and the ultrasound examination
was performed in a tertiary or referral centre in three studies
(Sinkala 2009-l; Weber 2018-h; Ndege 2019-h). We rated three
studies at unclear concern as the setting in which the ultrasound
was done was not reported (Monill-Serra 1997-l; Dominguez-
Castellano 1998-l; Kaneria 2009-l). In the index test domain we
judged five studies (56%) to be at unclear risk of bias because
four studies did not specify (or it was unclear) whether index
test results were interpreted without knowledge of the results
of the reference standard (Monill-Serra 1997-l; O'Keefe 1998-h;
Kaneria 2009-l; Weber 2018-h), and three studies did not report
prespecified thresholds (O'Keefe 1998-h; Kaneria 2009-l; Sinkala
2009-l). We considered the conduct and interpretation of the index
test to be of high concern for applicability in one study where the
ultrasound was performed by a trained radiologist (O'Keefe 1998-
h); we rated four studies at unclear concern since we were not able
to make a decision on the qualification of the person performing
the index tests (Monill-Serra 1997-l; Barreiros 2008-h; Kaneria 2009-
l; Sinkala 2009-l). Five studies (56%) used a lower-quality reference
standard and were deemed at high risk of bias in the reference
standard domain (Monill-Serra 1997-l; Dominguez-Castellano 1998-
l; Barreiros 2008-h; Kaneria 2009-l; Sinkala 2009-l). We rated five
studies at high concern for applicability for the reference standard
since mycobacteria isolated in culture were not speciated (Monill-
Serra 1997-l; Barreiros 2008-h; Kaneria 2009-l; Sinkala 2009-l;
Weber 2018-h). For the flow and timing domain, we considered one
study to be at high risk of bias because not all participants received
a reference standard and not all participants received the same
reference standard (Kaneria 2009-l). Four studies were deemed to
be at unclear risk of bias since: i) three studies did not report the
interval between the index test and the reference standard, and it
was unclear if all participants received the same reference standard
(Monill-Serra 1997-l; Dominguez-Castellano 1998-l; Barreiros 2008-
h); and ii) one study did not report the interval between the index
test and the reference standard, and not all participants received
the same reference standard (O'Keefe 1998-h).
Findings
For the diagnostic accuracy of abdominal ultrasound (main and
secondary analyses), the 11 studies included 1319 participants. The
median number of participants in the studies was 100 (interquartile
range (IQR) 58 to 134). The proportion of tuberculosis cases in
the non-case-control studies ranged from 17.5% (Sculier 2010-h)
to 71.0% (Sinkala 2009-l), median 40.6% (IQR 27.5 to 53.7). Table
1 present key characteristics for each of the 11 studies. Three
studies used a case-control design (Monill-Serra 1997-l; Barreiros
2008-h; Kaneria 2009-l) and eight studies used cross-sectional
or cohort design (Dominguez-Castellano 1998-h; O'Keefe 1998-h;
Sinkala 2009-l; Sculier 2010-h; Weber 2018-h; Bobbio 2019-l; Griesel
2019-h; Ndege 2019-h). Eight studies (73%) were conducted in low-
income or middle-income countries, while the remaining three
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studies were conducted in high-income countries. Results of the
primary and secondary analyses are summarized in Table 3.
I. Any abnormal abdominal ultrasound finding for tuberculosis
detection
We included six of the 11 studies in the primary analyses
(Dominguez-Castellano 1998-h; Dominguez-Castellano 1998-l;
Sculier 2010-h; Weber 2018-h; Weber 2018-l; Bobbio 2019-l; Griesel
2019-h; Ndege 2019-h; Ndege 2019-l); three studies provided data
for each type of reference standard.
Five studies (879 participants) used a higher-quality reference
standard (Dominguez-Castellano 1998-h; Sculier 2010-h; Weber
2018-h; Griesel 2019-h; Ndege 2019-h). Study estimates of
sensitivity and specificity ranged from 35% to 82% and from 20% to
92%. The pooled sensitivity and specificity were 63% (95% CI 43%
to 79%) and 68% (95% CI 42% to 87%), respectively (Figure 4).
 
Figure 4.   Forest plot of abdominal ultrasound for detecting abdominal TB or disseminated TB with abdominal
involvement. TP = true positive; FP = false positive; FN = false negative; TN = true negative. SuHix (h) indicates
higher quality reference standard; suHix (l) indicates lower quality reference standard.
 
Four studies (397 participants) used a lower-quality reference
standard (Dominguez-Castellano 1998-l; Weber 2018-l; Bobbio
2019-l; Ndege 2019-l). Sensitivity estimates ranged from 37% to
88% and specificity estimates ranged from 22% to 92% (Figure 4).
The pooled sensitivity and specificity were 68% (95% CI 45% to
85%) and 73% (95% CI 41% to 91%), respectively.
II. Splenic lesions on abdominal ultrasound for tuberculosis
detection
We included six studies involving 916 participants, of whom 477
had tuberculosis (Monill-Serra 1997-l; Dominguez-Castellano 1998-
l; Kaneria 2009-l; Weber 2018-h; Griesel 2019-h; Ndege 2019-h).
Sensitivity estimates were very heterogeneous and ranged from
13% to 62%. Specificity estimates were less heterogeneous and
ranged from 86% to 100% (Figure 5).
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Figure 5.   Forest plot of individual findings on ultrasound for detecting abdominal TB or disseminated TB with
abdominal involvement. TP = true positive; FP = false positive; FN = false negative; TN = true negative. SuHix (h)
indicates higher quality reference standard; suHix (l) indicates lower quality reference standard.
 
III. Intra-abdominal lymph nodes on abdominal ultrasound for
tuberculosis detection
Eight studies involving 917 participants (included 455 tuberculosis
cases) reported on intra-abdominal lymph nodes on abdominal
ultrasound (Monill-Serra 1997-l; Dominguez-Castellano 1998-l;
O'Keefe 1998-h; Barreiros 2008-h; Sinkala 2009-l; Weber 2018-h;
Griesel 2019-h; Ndege 2019-h). The sensitivities ranged from 22% to
86% and specificities from 56% to 100% (Figure 5).
IV. Ascites on abdominal ultrasound for tuberculosis detection
We included eight studies involving 891 participants, of whom 433
had tuberculosis (Monill-Serra 1997-l; O'Keefe 1998-h; Barreiros
2008-h; Kaneria 2009-l; Sinkala 2009-l; Weber 2018-h; Griesel 2019-
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h; Ndege 2019-h). Sensitivity and specificity estimates were very
heterogeneous and ranged from 4% to 73% and from 33% to 100%
respectively (Figure 5).
V. Splenomegaly
Six studies (775 participants, 397 tuberculosis cases) reported
splenomegaly (Monill-Serra 1997-l; Barreiros 2008-h; Kaneria 2009-
l; Sinkala 2009-l; Griesel 2019-h; Ndege 2019-h). Estimates were very
heterogeneous and ranged from 5% to 62% for sensitivity and 45%
to 89% for specificity (Figure 5).
VI. Hepatomegaly
Four studies (373 participants, of whom 189 had tuberculosis) were
included for hepatomegaly. The sensitivity ranged from 24% to 76%
and specificity from 20% to 78% (Figure 5).
Investigations of heterogeneity
We did not investigate heterogeneity, due to limited data.
D I S C U S S I O N
This systematic review of the diagnostic accuracy of abdominal
ultrasound for diagnosing abdominal tuberculosis or disseminated
tuberculosis with abdominal involvement in HIV-positive
individuals summarizes the current literature and includes 11
studies. Six studies reported on abdominal ultrasound with
any abnormal finding, and nine studies reported on individual
ultrasound findings. Studies were conducted in low-, middle- and
high-income countries. Five studies were performed in referral
or tertiary-level healthcare facilities, and in four studies the
ultrasound examinations were performed by radiologists.
Summary of main results
We have summarized the main results in Summary of findings 1.
An abdominal ultrasound with any abnormal finding had a pooled
sensitivity of 63% (95% CI 43% to 79%) and a pooled specificity
of 68% (95% CI 42% to 87%) when bacteriological confirmation
was used as the (higher-quality) reference standard. The pooled
sensitivity was 68% (95% CI 45% to 85%) and the pooled specificity
was 73% (95% CI 41% to 91%) when the reference standard was
clinical diagnosis without microbiological confirmation (lower-
quality reference standard).
The sensitivity of abdominal ultrasound is of concern, due to the
high chance of missing tuberculosis cases (high false negative rate).
This means that HIV-positive individuals who have tuberculosis
may be wrongly classified as not having tuberculosis, with a delay
in initiating appropriate treatment. Ultrasound examination is
operator-dependent and subjective, with the possibility of missing
subtle signs. Ultrasound also evaluates anatomical changes, and
abnormalities might not occur in individuals with advanced
immunosuppression.
The eIect of the type of reference standard used is reflected
in the improvement in both the sensitivity and specificity in
the lower-quality reference standard group. The primary concern
with a lower-quality reference standard (clinical diagnosis) is that
clinicians may overdiagnose tuberculosis for fear of missing or
delaying a diagnosis that could result in excess morbidity and
mortality, particularly among HIV-postive adults. This would result
in an overestimation of the diagnostic accuracy of abdominal
ultrasound, as fewer false positive and negative results would
occur. In addition, in studies where abdominal ultrasound is part of
the reference standard, incorporation bias would further result in
an overestimation of diagnostic accuracy.
The estimates of sensitivity for the primary and secondary
analyses were low and very heterogeneous. This means that
a negative abdominal ultrasound should not be used to rule
out abdominal tuberculosis or disseminated tuberculosis with
abdominal involvement.
Specificity estimates were very heterogeneous, especially for
hepatomegaly and splenomegaly.
Application of the main meta-analytic findings to a
hypothetical cohort
The main findings of the review were illustrated by applying the
results to a hypothetical cohort of 1000 HIV-positive individuals
thought to have tuberculosis. We presented diIerent scenarios
where the tuberculosis prevalence varies from 10% to 20% to
40%. The consequences of false positive results are probably
unnecessary initiation of treatment, additional testing with
subsequent morbidity, patient anxiety, and possible delay in
further diagnostic evaluation. The consequences of false negative
results are the continued risk of community transmission of
tuberculosis and an increased risk of patient morbidity and
mortality.
If the pooled estimates (from using a higher-quality reference
standard) for an abdominal ultrasound with any abnormal finding
are applied to a hypothetical cohort of 1000 HIV-positive individuals
where 100 (10%) of them actually have tuberculosis, abdominal
ultrasound would be expected to miss 37 tuberculosis cases and
falsely diagnose 288 people as tuberculosis cases (Summary of
findings 1). For a prevalence of 20% (200 tuberculosis cases),
74 tuberculosis cases will be missed and 256 people will be
falsely diagnosed as having tuberculosis (Figure 6) while for a
prevalence of 40% (400 tuberculosis cases), 148 tuberculosis cases
will be missed and 192 people will be falsely diagnosed as having
tuberculosis (Summary of findings 1).
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Figure 6.   Flow diagram summarizing the main results in hypothetical cohort with TB prevalence 20%
 
Strengths and weaknesses of the review
The findings in this review are based on comprehensive literature
searches, strict inclusion criteria, and standardized data extraction.
The search included studies published in all languages and
we corresponded with study authors to obtain additional and
unpublished data. However, as diagnostic accuracy studies are
poorly indexed, we acknowledge that we may have missed some
studies despite the comprehensive search.
The main limitations of the review were the small number of
studies and participants included in the analyses. The results were
very heterogeneous with a high false negative rate, and should
therefore be interpreted with caution. The high risks of bias in
the patient selection domain and the reference standard domain
further weaken our confidence in the results. A further limitation
in the reference standard was the use of microscopic identification
of acid-fast bacilli on stained sputum smears. Although smear
positivity has high specificity in high tuberculosis prevalence
settings, it is not a perfect reference standard as smear will also
detect non-tuberculous mycobacteria, which are found in a higher
proportion in low-prevalence tuberculosis settings.
Applicability of findings to the review question
We had high concern about the applicability of the included
studies to our review question. We foresee that in clinical practice
abdominal ultrasound to diagnose abdominal tuberculosis or
disseminated tuberculosis with abdominal involvement in HIV-
positive individuals would be most beneficial when performed
by non-radiologists in non-tertiary endemic settings. Most studies
were performed in tertiary settings with trained radiologists or
sonographers performing the ultrasound examination, and it is
possible that the accuracy of abdominal ultrasound may be lower
when performed in a diIerent setting or by less experienced
users. The predictive values of any diagnostic test are influenced
by disease prevalence, so the inclusion of studies performed
in low tuberculosis-burden countries would have decreased the
positive predictive value of abdominal ultrasound. Two studies
included HIV-positive participants without a clinical suspicion of
tuberculosis. In these studies, abdominal ultrasound has been used
as a screening test and not a diagnostic test. This will further aIect
the diagnostic accuracy of abdominal ultrasound and increase
the risk of inappropriate additional testing and initiation of anti-
tuberculous treatment. Studies were carried out under research
conditions, and it is possible that the diagnostic accuracy of
abdominal ultrasound might be lower in routine practice.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
Abdominal ultrasound had a sensitivity of 63% among HIV-
positive individuals suspected of having abdominal tuberculosis or
disseminated tuberculosis with abdominal involvement. The high
false negative rate suggests that ultrasound cannot be relied on
alone for the diagnosis of tuberculosis. The specificity of 68% of
any abnormal finding on abdominal ultrasound further indicates
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that care must be taken to not use abdominal ultrasound alone to
rule in tuberculosis, as the false positive rate is high. The presence
of individual findings such as ascites, splenic lesions and intra-
abdominal lymphadenopathy had a higher specificity as evidenced
by the range of study estimates, and, if proven in large prospective
studies, might be a useful indicator for tuberculosis involving the
abdomen. In light of our review findings, the intended role for
ultrasound is to be used with other tests, such as lateral flow urine
lipoarabinomannan assay (LF-LAM), chest x-ray and Xpert MTB/RIF
or Xpert Ultra, to confirm the diagnosis of abdominal tuberculosis
or disseminated tuberculosis with abdominal involvement.
Implications for research
Future studies that evaluate the diagnostic accuracy of abdominal
ultrasound in HIV-positive people should use a robust reference
standard with speciation to ensure that tuberculosis is correctly
diagnosed. Larger, prospective, well-designed studies that recruit a
representative sample of participants are also needed. The role of
abdominal ultrasound in addition to existing diagnostic strategies
(e.g. chest x-ray, LF-LAM, Xpert MTB/RIF) needs to be evaluated, as
well as its incorporation into tuberculosis diagnostic algorithms.
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Characteristics of included studies [ordered by study ID]
 
Study characteristics
Patient sampling Case-control design
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Patient characteristics and setting Country: Germany
Setting: Not reported
High tuberculosis burden country: No
High HIV-associated tuberculosis burden country: No
Sample size: 7 cases (of these 3 HIV-negative); 18 controls (of these 9
HIV-negative)
Median age (range): Cases 41 (27 - 66); Controls 36 (21 - 69)
Gender proportion (M:F): Cases 3:4; Controls 11:7
Proportion on antiretroviral therapy (ART): Not reported
Index tests Sonographer qualification: Not reported
Threshold(s):
• Thickened bowel wall: > 5 mm;
• Intramural abscess: thickened hypervascular bowel wall > 8 mm with
non-vascularized, oval-shaped, intramural mass-like lesions;
• Extramural abscess: Circumscribed hypoechoic or echo-free fluid col-
lections > 10 mm next to fistula;
• Lymph nodes: Longitudinal diameter > 20 mm;
• Splenomegaly: > 13.5 cm
Target condition and reference standard(s) Target condition: Intestinal tuberculosis
Confirmation of active tuberculosis: “…based on clinical, endoscopic,
histologic, radiologic and operative findings including microbiology (in
all) and polymerase chain reaction (PCR) (in 5 patients) of biopsies tak-
en during endoscopy.”
Flow and timing  
Comparative  
Notes Second control group of healthy persons not included
4 cases and 9 controls were HIV-positive
Cases had pulmonary tuberculosis only (randomly selected)
Reference standard results not delineated
Methodological quality
Item Authors' judgement Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients en-
rolled?
Yes    
Was a case-control design avoided? No    
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Did the study avoid inappropriate exclusions? Yes    
    High High
DOMAIN 2: Index Test Ascites
Were the index test results interpreted without knowledge
of the results of the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
    Low Unclear
DOMAIN 2: Index Test Abdominal lymph nodes
Were the index test results interpreted without knowledge
of the results of the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
    Low Unclear
DOMAIN 2: Index Test Splenomegaly
Were the index test results interpreted without knowledge
of the results of the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
    Low Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the
target condition?
No    
Were the reference standard results interpreted without
knowledge of the results of the index tests?
Unclear    
Was incorporation bias avoided? Yes    
    High High
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and
reference standard?
Unclear    
Did all patients receive the same reference standard? Unclear    
Were all patients included in the analysis? Yes    
Did all patients received a reference standard? Yes    
    Unclear  
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Patient sampling Cross-sectional design
Patient characteristics and setting Country: South Sudan
Setting: Referral hospital
High tuberculosis burden country: No
High HIV-associated tuberculosis burden country: No
Sample size: 100
Median age (range): Not available (only categories available)
Gender proportion (M:F): 48:52
Proportion on antiretroviral therapy (ART): 3%
Index tests Sonographer qualification: Clinician trained in ultrasound
Threshold(s): At least one of
• Pericardial effusion;
• Periportal/para-aortic lymph nodes (> 1.5 cm in diameter);
• Focal splenic lesions;
• Pleural effusion or consolidation of lung;
• Ascites without alternative explanation;
• Focal liver lesion
Target condition and reference standard(s) Target condition: Disseminated tuberculosis
Confirmation of active tuberculosis: Acid-fast bacilli sputum
smears, ultrasound, clinical diagnosis




Item Authors' judgement Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? No    
Was a case-control design avoided? Yes    
Did the study avoid inappropriate exclusions? Yes    
    High High
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DOMAIN 2: Index Test Abnormal abdominal ultrasound (lower quality)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
    Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
No    
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
No    
Was incorporation bias avoided? No    
    High High
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
Yes    
Did all patients receive the same reference standard? No    
Were all patients included in the analysis? Yes    
Did all patients received a reference standard? No    





Patient sampling Prospective cross-sectional
Patient characteristics and setting Country: Spain
Setting: Not reported
High tuberculosis burden country: No
High HIV-associated tuberculosis burden country: No
Sample size:116
Age: 31.56 ± 4.68 years (mean ± SD)
Gender proportion: Not reported
Proportion on antiretroviral therapy (ART): Not reported
Index tests Sonographer qualification: “Medical sonographer”
Dominguez-Castellano 1998-h 
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Threshold(s):
• Multiple splenic focal lesions: hypoechoic, < 10 mm diameter, poor-
ly-defined / irregular borders, homogeneous distribution;
• Abdominal adenopathy: hypo or isoechoic, between 1 and 3 cm,
around hepatic hilum, spleen, aorta or celiac trunk;
• Hypo or hyperechoic focal liver lesions
Target condition and reference standard(s) Target condition: Pulmonary tuberculosis, Extra-pulmonary tubercu-
losis and disseminated tuberculosis (with or without abdominal in-
volvement)
Confirmation of active tuberculosis: Smear microscopy, Lowenstein
culture




Item Authors' judgement Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Yes    
Was a case-control design avoided? Yes    
Did the study avoid inappropriate exclusions? Yes    
    Low Unclear
DOMAIN 2: Index Test Abnormal abdominal ultrasound (higher quality)
Were the index test results interpreted without knowledge
of the results of the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
    Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the tar-
get condition?
Yes    
Were the reference standard results interpreted without
knowledge of the results of the index tests?
Yes    
Was incorporation bias avoided? Yes    
    Low Low
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DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and
reference standard?
Unclear    
Did all patients receive the same reference standard? Unclear    
Were all patients included in the analysis? Yes    
Did all patients received a reference standard? Yes    





Patient sampling Prospective cross-sectional
Patient characteristics and setting Country: Spain
Setting: Not reported
High tuberculosis burden country: No
High HIV-associated tuberculosis burden country: No
Sample size:116
Age: 31.56 ± 4.68 years (mean ± SD)
Gender proportion: Not reported
Proportion on antiretroviral therapy (ART): Not reported
Index tests Sonographer qualification: “Medical sonographer”
Threshold(s):
• Multiple splenic focal lesions: hypoechoic, < 10 mm diame-
ter, poorly-defined / irregular borders, homogeneous distri-
bution;
• Abdominal adenopathy: hypo or isoechoic, between 1 cm
and 3 cm, around hepatic hilum, spleen, aorta or celiac
trunk;
• Hypo or hyperechoic focal liver lesions
Target condition and reference standard(s) Target condition: Pulmonary tuberculosis, extra-pulmonary
tuberculosis and disseminated tuberculosis (with or without
abdominal involvement)
Confirmation of active tuberculosis: Compatible with clinical
and radiography findings with improvement to anti-tubercu-
losis treatment
Flow and timing  
Dominguez-Castellano 1998-l 
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Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Yes    
Was a case-control design avoided? Yes    
Did the study avoid inappropriate exclusions? Yes    
    Low Unclear
DOMAIN 2: Index Test Abnormal abdominal ultrasound (lower quality)
Were the index test results interpreted without knowledge of the re-
sults of the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
    Low Low
DOMAIN 2: Index Test Splenic lesions
Were the index test results interpreted without knowledge of the re-
sults of the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
    Low Low
DOMAIN 2: Index Test Abdominal lymph nodes
Were the index test results interpreted without knowledge of the re-
sults of the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
    Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target con-
dition?
No    
Were the reference standard results interpreted without knowledge
of the results of the index tests?
No    
Was incorporation bias avoided? Unclear    
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    High Low
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference
standard?
Unclear    
Did all patients receive the same reference standard? Unclear    
Were all patients included in the analysis? Yes    
Did all patients received a reference standard? Yes    





Patient sampling Prospective cross-sectional
Patient characteristics and setting Country: South Africa
Setting: Secondary-level hospitals
High tuberculosis burden country: Yes
High HIV-associated tuberculosis burden country: Yes
Sample size: 377
Age: Median (IQR) tuberculosis cases: 35 (30 - 41);
Non-tuberculosis controls: 36 (30 - 42)
Gender proportion (M:F) tuberculosis cases: 64:137;
Non-tuberculosis controls: 64:112
Proportion on antiretroviral therapy (ART): tubercu-
losis cases: 59/201 (29%); Non-tuberculosis controls:
61/176 (35%)
Index tests Sonographer qualification: Trained sonographers
Threshold(s):
• Lymph nodes (long-axis length: any and ≥ 10 mm in
diameter);
• Splenic hypoechoic lesions;
• Spleen enlargement ≥ 110 mm;
• Any one of abdominal, pleural, or pericardial effu-
sions
Target condition and reference standard(s) Target condition: Tuberculosis
Confirmation of active tuberculosis: Positive culture
for M tuberculosis
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Risk of bias Applicability
concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Yes    
Was a case-control design avoided? Yes    
Did the study avoid inappropriate exclusions? No    
    High Low
DOMAIN 2: Index Test Abnormal abdominal ultrasound (higher quality)
Were the index test results interpreted without knowledge of the results of
the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
    Low Low
DOMAIN 2: Index Test Ascites
Were the index test results interpreted without knowledge of the results of
the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
    Low Low
DOMAIN 2: Index Test Splenic lesions
Were the index test results interpreted without knowledge of the results of
the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
    Low Low
DOMAIN 2: Index Test Abdominal lymph nodes
Were the index test results interpreted without knowledge of the results of
the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
    Low Low
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DOMAIN 2: Index Test Splenomegaly
Were the index test results interpreted without knowledge of the results of
the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
    Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition? Yes    
Were the reference standard results interpreted without knowledge of the
results of the index tests?
Yes    
Was incorporation bias avoided? Yes    
    Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference stan-
dard?
Unclear    
Did all patients receive the same reference standard? Yes    
Were all patients included in the analysis? Yes    
Did all patients received a reference standard? Yes    






Patient characteristics and setting Country: India
Setting: Not reported
High tuberculosis burden country: Yes
High HIV-associated tuberculosis burden country: Yes
Sample size: 90
Age: Mean (range) Cases: Male 36.4 (24 - 60), Female
33.41 (25 - 60); Controls: Male 39.46 (24 - 60), Female
38.71 (25 - 61)
Gender proportion: M:F Cases: 31:14; Controls: 30:15
Kaneria 2009-l 
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Proportion on antiretroviral therapy (ART): Cases: 7/45
(15.6%); Controls: 15/30 (50%)
Index tests Sonographer qualification: Not reported
Threshold(s): Not reported
Target condition and reference standard(s) Target condition: Pulmonary tuberculosis, extra-pul-
monary tuberculosis and disseminated tuberculosis
(with or without abdominal involvement)
Confirmation of active tuberculosis: Microscopic identi-
fication of AFB and compatible clinical findings






Risk of bias Applicability
concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear    
Was a case-control design avoided? No    
Did the study avoid inappropriate exclusions? Yes    
    High Unclear
DOMAIN 2: Index Test Ascites
Were the index test results interpreted without knowledge of the results of
the reference standard?
Unclear    
If a threshold was used, was it pre-specified? No    
    Unclear Unclear
DOMAIN 2: Index Test Splenic lesions
Were the index test results interpreted without knowledge of the results of
the reference standard?
Unclear    
If a threshold was used, was it pre-specified? No    
    Unclear Unclear
DOMAIN 2: Index Test Splenomegaly
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If a threshold was used, was it pre-specified? No    
    Unclear Unclear
DOMAIN 2: Index Test Hepatomegaly
Were the index test results interpreted without knowledge of the results of
the reference standard?
Unclear    
If a threshold was used, was it pre-specified? No    
    Unclear Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition? No    
Were the reference standard results interpreted without knowledge of the
results of the index tests?
Unclear    
Was incorporation bias avoided? Unclear    
    High High
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference stan-
dard?
Unclear    
Did all patients receive the same reference standard? No    
Were all patients included in the analysis? Yes    
Did all patients received a reference standard? No    






Patient characteristics and setting Country: Spain
Setting: Not reported
High tuberculosis burden country: No
High HIV-associated tuberculosis burden country: No
Sample size: 152
Age: Cases: Mean 30; Range 20 - 49; Controls: Not re-
ported
Monill-Serra 1997-l 
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Gender proportion: M:F Cases: 56:20; Controls: Not re-
ported
Proportion on antiretroviral therapy (ART): Not report-
ed
Index tests Sonographer qualification: Not reported
Threshold(s):
• Lymph nodes > 1.5 cm;
• Splenomegaly long axis > 12 cm or subjective impres-
sion;
• Hypoechoic splenic lesions 0.5 cm to 1.0 cm (Not pre-
specified)
Target condition and reference standard(s) Target condition: Disseminated tuberculosis (with or
without abdominal involvement)
Confirmation of active tuberculosis: Microbiological
(culture) or histopathological examination
Flow and timing  
Comparative  
Notes Controls were HIV-positive with no associated neoplas-




Risk of bias Applicability
concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear    
Was a case-control design avoided? No    
Did the study avoid inappropriate exclusions? No    
    High Unclear
DOMAIN 2: Index Test Ascites
Were the index test results interpreted without knowledge of the results of
the reference standard?
Unclear    
If a threshold was used, was it pre-specified? Yes    
    Unclear Unclear
DOMAIN 2: Index Test Splenic lesions
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If a threshold was used, was it pre-specified? Yes    
    Unclear Unclear
DOMAIN 2: Index Test Abdominal lymph nodes
Were the index test results interpreted without knowledge of the results of
the reference standard?
Unclear    
If a threshold was used, was it pre-specified? Yes    
    Unclear Unclear
DOMAIN 2: Index Test Splenomegaly
Were the index test results interpreted without knowledge of the results of
the reference standard?
Unclear    
If a threshold was used, was it pre-specified? Yes    
    Unclear Unclear
DOMAIN 2: Index Test Hepatomegaly
Were the index test results interpreted without knowledge of the results of
the reference standard?
Unclear    
If a threshold was used, was it pre-specified? Yes    
    Unclear Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition? No    
Were the reference standard results interpreted without knowledge of the
results of the index tests?
Yes    
Was incorporation bias avoided? Yes    
    High High
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference stan-
dard?
Unclear    
Did all patients receive the same reference standard? Unclear    
Were all patients included in the analysis? Yes    
Did all patients received a reference standard? Yes    
    Unclear  
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Study characteristics
Patient sampling Prospective cohort
Patient characteristics and setting Country: Tanzania
Setting: Referral hospital
High tuberculosis burden country: Yes
High HIV-associated tuberculosis burden country: Yes
Sample size: 100 (original study size including HIV-neg-
ative n = 191)
Age: Median 38 years; IQR 32 - 44 years
Gender proportion: M:F 47:53
Proportion on antiretroviral therapy (ART): 56%
Index tests Sonographer qualification: Board-certified sonogra-
phers
Threshold(s):
• Original FASH: pleural or pericardial effusion, ascites,
abdominal lymph nodes > 1.5 cm, hypoechogenic le-
sions in the liver or spleen, ileum wall thickening > 4
mm or destructed ileum wall architecture;
• Splenomegaly > 140 mm in long axis;
• Hepatomegaly ≥ 2 cm below costal margin;
• Pleural or pericardial fibrin strands in presence of ef-
fusion
Target condition and reference standard(s) Confirmed tuberculosis was defined as ≥ 1 positive mi-
crobiological result from any site confirmed by Xpert
MTB/RIF assay and/or bacteriologic culture (growth of
M tuberculosis) in sputum, pleural fluid, ascites, cere-
brospinal fluid, urine or lymph node aspirate






Risk of bias Applicability
concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Yes    
Was a case-control design avoided? Yes    
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Did the study avoid inappropriate exclusions? Yes    
    Low High
DOMAIN 2: Index Test Abnormal abdominal ultrasound (higher quality)
Were the index test results interpreted without knowledge of the results of
the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
    Low Low
DOMAIN 2: Index Test Ascites
Were the index test results interpreted without knowledge of the results of
the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
    Low Low
DOMAIN 2: Index Test Splenic lesions
Were the index test results interpreted without knowledge of the results of
the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
    Low Low
DOMAIN 2: Index Test Abdominal lymph nodes
Were the index test results interpreted without knowledge of the results of
the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
    Low Low
DOMAIN 2: Index Test Splenomegaly
Were the index test results interpreted without knowledge of the results of
the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
    Low Low
DOMAIN 2: Index Test Hepatomegaly
Were the index test results interpreted without knowledge of the results of
the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
Ndege 2019-h  (Continued)
Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV-positive
individuals (Review)










Cochrane Database of Systematic Reviews
    Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition? Yes    
Were the reference standard results interpreted without knowledge of the
results of the index tests?
Yes    
Was incorporation bias avoided? Yes    
    Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference stan-
dard?
Yes    
Did all patients receive the same reference standard? Yes    
Were all patients included in the analysis? Yes    
Did all patients received a reference standard? Yes    





Patient sampling Prospective cohort
Patient characteristics and setting Country: Tanzania
Setting: Referral hospital
High tuberculosis burden country: Yes
High HIV-associated tuberculosis burden country: Yes
Sample size: 100 (original study size including HIV-negative n = 191)
Age: Median 38 years; IQR 32 - 44 years
Gender proportion: M:F 47:53
Proportion on antiretroviral therapy (ART): 56%
Index tests Sonographer qualification: Board-certified sonographers
Threshold(s):
• Original FASH: pleural or pericardial effusion, ascites, abdominal lymph nodes > 1.5
cm, hypoechogenic lesions in the liver or spleen, ileum wall thickening > 4 mm or de-
structed ileum wall architecture;
• Splenomegaly > 140 mm in long axis;
• Hepatomegaly ≥ 2 cm below costal margin;
Ndege 2019-l 
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• Pleural or pericardial fibrin strands in presence of effusion
Target condition and reference stan-
dard(s)
Confirmed tuberculosis was defined as ≥ 1 positive microbiological result from any site
confirmed by Xpert MTB/RIF assay and/or bacteriologic culture (growth of M tuberculo-
sis) in sputum, pleural fluid, ascites, cerebrospinal fluid, urine or lymph node aspirate.
In addition, the identification of acid-fast bacilli in sputum by another health centre, or
adenosine deaminase (ADA) ≥ 40 U/ml in pleural fluid, ≥ 35 U/ml in pericardial fluid and
≥ 30 U/ml in ascitic fluid were accepted as microbiological confirmation. Probable tu-
berculosis was defined as negative microbiological tests in a participant in whom an-
ti-tuberculosis therapy (prescribed based on clinical suspicion or on chest x-ray) in the
absence of an alternative diagnosis led to a resolution of clinical signs and symptoms,
radiographic and sonographic signs, and to an increase in body weight documented 2
months after start of anti-tuberculosis treatment




Item Authors' judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of
patients enrolled?
Yes    
Was a case-control design avoided? Yes    
Did the study avoid inappropriate exclu-
sions?
Yes    
    Low High
DOMAIN 2: Index Test Abnormal abdominal ultrasound (lower quality)
Were the index test results interpreted
without knowledge of the results of the
reference standard?
Yes    
If a threshold was used, was it pre-speci-
fied?
Yes    
    Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely to cor-
rectly classify the target condition?
No    
Were the reference standard results inter-
preted without knowledge of the results
of the index tests?
Yes    
Was incorporation bias avoided? Unclear    
Ndege 2019-l  (Continued)
Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV-positive
individuals (Review)










Cochrane Database of Systematic Reviews
    High Low
DOMAIN 4: Flow and Timing
Was there an appropriate interval be-
tween index test and reference standard?
Yes    
Did all patients receive the same refer-
ence standard?
No    
Were all patients included in the analysis? Yes    
Did all patients received a reference stan-
dard?
Yes    





Patient sampling Prospective cross-sectional
Patient characteristics and setting Country: South Africa
Setting: Non-tertiary setting
High tuberculosis burden country: Yes
High HIV-associated tuberculosis burden country: Yes
Sample size: 35 (original study size n = 44)
Age: Mean 32.9; Range 18.4 - 53.3
Gender proportion: M:F 26:18
Proportion on antiretroviral therapy (ART): 0/44 (0%)
Index tests Sonographer qualification: Radiologist
Threshold(s): Not reported
Target condition and reference standard(s) Target condition: Disseminated tuberculosis with ab-
dominal involvement)
Confirmation of active tuberculosis: Microbiological
(culture) or postmortem evidence
Flow and timing  
Comparative  
Notes Only 35/44 had ultrasound examination
Methodological quality
O'Keefe 1998-h 
Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV-positive
individuals (Review)










Cochrane Database of Systematic Reviews
Item Authors' judge-
ment
Risk of bias Applicability
concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Yes    
Was a case-control design avoided? Yes    
Did the study avoid inappropriate exclusions? No    
    High Low
DOMAIN 2: Index Test Ascites
Were the index test results interpreted without knowledge of the results of
the reference standard?
Unclear    
If a threshold was used, was it pre-specified? No    
    Unclear High
DOMAIN 2: Index Test Abdominal lymph nodes
Were the index test results interpreted without knowledge of the results of
the reference standard?
Unclear    
If a threshold was used, was it pre-specified? No    
    Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition? Yes    
Were the reference standard results interpreted without knowledge of the
results of the index tests?
Yes    
Was incorporation bias avoided? Yes    
    Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference stan-
dard?
Unclear    
Did all patients receive the same reference standard? No    
Were all patients included in the analysis? Yes    
Did all patients received a reference standard? Yes    
    Unclear  
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Study characteristics
Patient sampling Prospective cross-sectional
Patient characteristics and setting Country: Cambodia
Setting: “not-for-profit referral hospital”
High tuberculosis burden country: Yes
High HIV-associated tuberculosis burden country: No
Sample size: 212
Age: Median (IQR) 34 (29 - 41.5) years (included participants <
18 years)
Gender proportion: M 40%, F 60%
Proportion on antiretroviral therapy (ART): Not reported
Index tests Sonographer qualification: “Trained radiologist”
Threshold(s):




• Hepatic or splenic hypoechoic lesions with or without organ
enlargement
Target condition and reference standard(s) Target condition: Disseminated tuberculosis (with or without
abdominal involvement)
Confirmation of active tuberculosis: Culture






Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Yes    
Was a case-control design avoided? Yes    
Did the study avoid inappropriate exclusions? Yes    
    Low High
Sculier 2010-h 
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DOMAIN 2: Index Test Abnormal abdominal ultrasound (higher quality)
Were the index test results interpreted without knowledge of the re-
sults of the reference standard?
Yes    
If a threshold was used, was it pre-specified? Yes    
    Low High
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target con-
dition?
Yes    
Were the reference standard results interpreted without knowledge
of the results of the index tests?
Yes    
Was incorporation bias avoided? Yes    
    Low High
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference
standard?
Unclear    
Did all patients receive the same reference standard? Yes    
Were all patients included in the analysis? Yes    
Did all patients received a reference standard? Yes    





Patient sampling Prospective cross-sectional
Patient characteristics and setting Country: Zambia
Setting: “secondary and tertiary care hospital”
High tuberculosis burden country: Yes
High HIV-associated tuberculosis burden country: Yes
Sample size: 31
Age: Mean (SD) All: 33.4 (8.3) years (in text: mean 33.1 range 18 - 54); tu-
berculosis: 30.7 (6.9); No tuberculosis: 39.8 (8)
Gender proportion: M:F All: 8:23; tuberculosis: 7:15; No tuberculosis: 1:8
Proportion on antiretroviral therapy (ART): Not reported
Sinkala 2009-l 
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Index tests Sonographer qualification: Not reported
Threshold(s): Not reported
Target condition and reference standard(s) Target condition: Abdominal tuberculosis
Confirmation of active tuberculosis: “…definitive diagnosis of tubercu-
losis was made by demonstration of M tuberculosis infection via pos-
itive bacteriological culture and/or granulomatous inflammation on
histopathological examination with positive Ziehl-Neelsen (ZN) stain-
ing on microscopy. A presumptive diagnosis of tuberculosis was made
when granulomatous inflammation was seen on microscopy, or when
visual inspection on laparoscopy was consistent with tuberculosis and
the patient's clinical response to anti-tuberculous treatment was good.
Laparoscopic features felt to be consistent with tuberculosis for the
purpose of making a presumptive diagnosis were the presence of tuber-
cles, fibro adhesive peritonitis, or caseating lymphadenopathy.”
Flow and timing  
Comparative  
Notes Ultrasound used as part of inclusion and exclusion criteria (selection
bias)
Methodological quality
Item Authors' judgement Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients en-
rolled?
Yes    
Was a case-control design avoided? Yes    
Did the study avoid inappropriate exclusions? Yes    
    Low High
DOMAIN 2: Index Test Ascites
Were the index test results interpreted without knowledge
of the results of the reference standard?
Yes    
If a threshold was used, was it pre-specified? No    
    Low Unclear
DOMAIN 2: Index Test Abdominal lymph nodes
Were the index test results interpreted without knowledge
of the results of the reference standard?
Yes    
If a threshold was used, was it pre-specified? No    
    Unclear Unclear
Sinkala 2009-l  (Continued)
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DOMAIN 2: Index Test Splenomegaly
Were the index test results interpreted without knowledge
of the results of the reference standard?
Yes    
If a threshold was used, was it pre-specified? No    
    Unclear Unclear
DOMAIN 2: Index Test Hepatomegaly
Were the index test results interpreted without knowledge
of the results of the reference standard?
Yes    
If a threshold was used, was it pre-specified? No    
    Unclear Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the
target condition?
No    
Were the reference standard results interpreted without
knowledge of the results of the index tests?
No    
Was incorporation bias avoided? Yes    
    High High
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and
reference standard?
Unclear    
Did all patients receive the same reference standard? Yes    
Were all patients included in the analysis? Yes    
Did all patients received a reference standard? Yes    





Patient sampling Prospective controlled cohort
Patient characteristics and setting Country: India
Setting: Tertiary setting
High tuberculosis burden country: Yes
High HIV-associated tuberculosis burden country: Yes
Weber 2018-h 
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Sample size: 81 (original study size including HIV-negative n = 425)
Age: Overall median (IQR) 43 (31.5 - 55); HIV only 43 (38 - 48) (included
participants < 18 years)
Gender proportion: Overall: M 328/425 (77%); HIV-positive M 56/81
(69%)
Proportion on antiretroviral therapy (ART): 29/81 (35.8%)
Index tests Sonographer qualification: Clinician trained in the study’s ultrasound
protocol but without formal ultrasound training
Threshold(s):
• FASH: at least 1 of pericardial or pleural effusion, focal liver or splenic
lesions, or abdominal lymphadenopathy;
• Pericardial effusion: qualitative assessment;
• Focal liver lesions: Size 2 mm to 15 mm; multiple in appearance;
• Focal splenic lesions: Size 2 mm to 15 mm; multiple in appearance;
• Abdominal lymphadenopathy: Max diameter at least 15 mm
Target condition and reference standard(s) Target condition: Pulmonary tuberculosis and extra-pulmonary tuber-
culosis
Confirmation of active tuberculosis: “…’confirmed tuberculosis' (i.e.,
positive fluorescent microscopy, polymerase chain reaction, or tuber-
culosis culture)…”
Flow and timing  
Comparative  
Notes Includes patients ≥ 16 years
“…therapeutic and diagnostic management was fully the responsibility
of the attending hospital doctor.”
Additional info received from authors
Methodological quality
Item Authors' judgement Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients en-
rolled?
Yes    
Was a case-control design avoided? Yes    
Did the study avoid inappropriate exclusions? Yes    
    Low High
DOMAIN 2: Index Test Abnormal abdominal ultrasound (higher quality)
Weber 2018-h  (Continued)
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Were the index test results interpreted without knowledge
of the results of the reference standard?
No    
If a threshold was used, was it pre-specified? Yes    
    Unclear Low
DOMAIN 2: Index Test Ascites
Were the index test results interpreted without knowledge
of the results of the reference standard?
No    
If a threshold was used, was it pre-specified? Yes    
    Unclear Low
DOMAIN 2: Index Test Splenic lesions
Were the index test results interpreted without knowledge
of the results of the reference standard?
No    
If a threshold was used, was it pre-specified? Yes    
    Unclear Low
DOMAIN 2: Index Test Abdominal lymph nodes
Were the index test results interpreted without knowledge
of the results of the reference standard?
No    
If a threshold was used, was it pre-specified? Yes    
    Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the
target condition?
Yes    
Were the reference standard results interpreted without
knowledge of the results of the index tests?
Yes    
Was incorporation bias avoided? Yes    
    Low High
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and
reference standard?
Yes    
Did all patients receive the same reference standard? No    
Were all patients included in the analysis? Yes    
Did all patients received a reference standard? Yes    
Weber 2018-h  (Continued)
Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV-positive
individuals (Review)










Cochrane Database of Systematic Reviews





Patient sampling Prospective controlled cohort
Patient characteristics and setting Country: India
Setting: Tertiary setting
High tuberculosis burden country: Yes
High HIV-associated tuberculosis burden country: Yes
Sample size: 81 (original study size including HIV-negative n = 425)
Age: Overall median (IQR) 43 (31.5 - 55); HIV only 43 (38 - 48) (included participants <
18 years)
Gender proportion: Overall: M 328/425 (77%); HIV-positive M 56/81 (69%)
Proportion on antiretroviral therapy (ART): 29/81 (35.8%)
Index tests Sonographer qualification: Clinician trained in the study’s ultrasound protocol but
without formal ultrasound training
Threshold(s):
• FASH: at least 1 of pericardial or pleural effusion, focal liver or splenic lesions, or
abdominal lymphadenopathy;
• Pericardial effusion: qualitative assessment;
• Focal liver lesions: Size 2 mm to 15 mm; multiple in appearance;
• Focal splenic lesions: Size 2 mm to 15 mm; multiple in appearance;
• Abdominal lymphadenopathy: Max diameter at least 15 mm
Target condition and reference standard(s) Target condition: Pulmonary tuberculosis and extra-pulmonary tuberculosis
Confirmation of active tuberculosis: “…’clinical tuberculosis’ (no microbiological
confirmation, but clinical tuberculosis diagnosis and tuberculosis treatment initiat-
ed)…”
Flow and timing  
Comparative  
Notes Includes patients ≥ 16 years
“…therapeutic and diagnostic management was fully the responsibility of the at-
tending hospital doctor.”
Additional info received from authors
Methodological quality
Item Authors' judgement Risk of bias Applicability concerns
Weber 2018-l 
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DOMAIN 1: Patient Selection
Was a consecutive or random sample of pa-
tients enrolled?
Yes    
Was a case-control design avoided? Yes    
Did the study avoid inappropriate exclusions? Yes    
    Low High
DOMAIN 2: Index Test Abnormal abdominal ultrasound (lower quality)
Were the index test results interpreted with-
out knowledge of the results of the reference
standard?
No    
If a threshold was used, was it pre-specified? Yes    
    Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly
classify the target condition?
No    
Were the reference standard results interpret-
ed without knowledge of the results of the in-
dex tests?
No    
Was incorporation bias avoided? No    
    High Unclear
DOMAIN 4: Flow and Timing
Was there an appropriate interval between in-
dex test and reference standard?
Yes    
Did all patients receive the same reference
standard?
No    
Were all patients included in the analysis? Yes    
Did all patients received a reference stan-
dard?
Yes    
    Low  
Weber 2018-l  (Continued)
SuIix (h) indicates higher-quality reference standard; suIix (l) indicates lower-quality reference standard
 
Characteristics of excluded studies [ordered by study ID]
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Study Reason for exclusion
Abiri 1985 Descriptive study
Agarwal 2010 No reference standard
Akinkuolie 2008 Descriptive study
Aubry 1994 Descriptive study
Barthwal 2005 Descriptive study
Batra 2000 Descriptive study
Chen 2009 Descriptive study
Clarke 2007 Descriptive study
Emby 2002 Descriptive study
Feng 2016 Ineligible index test
Giordani 2013 Descriptive study
Heller 2010a Descriptive study
Heller 2013 Descriptive study
Heller 2017 Descriptive study
Ibrahim 2005 Descriptive study
Jain 1995 Ineligible patient population
Kedar 1994 Descriptive study
Landoni 2002 Descriptive study
Ouedraogo 2016 Only abnormal index test reported
Patel 2011 Only abnormal index test reported
Porcel-Martin 1998 Descriptive study
Sheikh 1999 Descriptive study
Solomon 1998 Not a diagnostic accuracy study
Soriano 1991 Descriptive study
Spalgais 2013 Descriptive study
Spalgais 2017 No reference standard
Tarantino 2003 Descriptive study
Tarantino 2004 Descriptive study
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Study Reason for exclusion
Tshibwabwa 2000 Ineligible patient population
Wafai 2017 Descriptive study
 
Characteristics of ongoing studies [ordered by study ID]
 
Trial name or title Ultrasound in managing tuberculosis: A randomized controlled two-center study
Target condition and refer-
ence standard(s)
Target condition: Extrapulmonary tuberculosis
Reference standard: Not stipulated
Index and comparator tests Index test: eFASH (extended focused assessment with sonography for HIV and tuberculosis) and a
management algorithm
Comparator group: Standard of care (Management according to the decision of the treating physi-
cian)






D A T A
Presented below are all the data for all of the tests entered into the review.
 
Table Tests.   Data tables by test
Test No. of studies No. of participants
1 Abnormal abdominal ultrasound (higher quality) 5 879
2 Abnormal abdominal ultrasound (lower quality) 4 397
3 Ascites 8 891
4 Splenic lesions 6 916
5 Abdominal lymph nodes 8 917
6 Splenomegaly 6 775
7 Hepatomegaly 4 373
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Test 1.   Abnormal abdominal ultrasound (higher quality).
 
 
Test 2.   Abnormal abdominal ultrasound (lower quality).
 
 
Test 3.   Ascites.
 
 
Test 4.   Splenic lesions.
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Test 5.   Abdominal lymph nodes.
 
 
Test 6.   Splenomegaly.
 
 
Test 7.   Hepatomegaly.
 
 
A D D I T I O N A L   T A B L E S
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Study design Country Clinical set-
ting













South Sudan Referral hos-
pital















Culture-positive tuberculosis Sonographer 377 53%
Kaneria 2009-l Case-control India Not reported Pulmonary tuberculosis, ex-
tra-pulmonary tuberculosis,
disseminated tuberculosis





































Abdominal tuberculosis Not reported 31 71%
Weber 2018-h; Weber
2018-l
Cohort India Tertiary hos-
pital
Disseminated tuberculosis Trained non-ra-
diologist
81 (425 original study
sample)
30% (higher)






















































































































































































































Table 1.   Key findings of included studies  (Continued)
aIncludes five HIV-negative participants.








































































Index test variable included (threshold) Reference standard quality and definition
Barreiros 2008-h Ascites (any)
Lymphadenopathy (abdominal and perihepatic nodes
with longitudinal diameter > 20 mm)
Splenomegaly (> 135 mm)
Lower: Clinical, endoscopic, histologic, radiolog-
ic and operative findings including microbiology
and polymerase chain reaction of biopsies taken
during endoscopy
Bobbio 2019-l Any abnormality (Presence of ≥ 1: i) pericardial effusion,
ii) periportal/para-aortic lymph nodes (> 15 mm diame-
ter), iii) focal splenic lesions, iv) pleural effusion or con-
solidation of the lung, v) ascites without alternative ex-
planation)
Lower: Sputum microscopy OR clinical reasons






Any abnormality (presence of ≥ 1: i) multiple hypoechoic
splenic lesions (< 10 mm), ii) any abdominal adenopathy,
iii) hypo- or hyperechoic liver lesions)
Higher: Microscopy OR culture
Lower: Microscopy OR culture OR clinical or ra-
diographic indications and response to treat-
ment
Griesel 2019-h Any abnormality (presence of ≥ 1: i) abdominal lymph
nodes (any size), ii) splenic hypoechoic lesions, iii)
splenomegaly (≥ 110 mm), iv) any one of abdominal,




Splenomegaly (≥ 110 mm)
Higher: Positive culture for M tuberculosis from
any site
Kaneria 2009-l Ascites (any)
Hepatomegaly (not defined)
Lymphadenopathy (diameter > 15 mm)
Splenic lesions (multiple, hypoechoic, 5 mm to 10 mm
diameter)
Splenomegaly (not defined)
Lower: Lymphocytic predominance and elevat-
ed adenosine deaminase (ADA) levels in pleural
or ascitic fluid OR granulomatous lymphadenitis
and acid-fast bacilli in lymph node OR sputum
microscopy
Monill-Serra 1997-l Ascites (any)
Hepatomegaly (not defined)
Lymphadenopathy (> 15 mm diameter)
Splenic lesions (hypoechoic nodes)
Splenomegaly (long axis > 120 mm or subjective impres-
sion)
Lower: Blood culture positive for M tuberculosis
OR medullary bone or liver biopsy with granulo-
matous inflammation or culture positive for M
tuberculosis OR microbiological or histopatho-




Any abnormality (presence of ≥ 1: i) pleural or pericardial
effusion, ii) ascites, iii) abdominal lymph nodes > 15 mm,
iv) hypoechogenic lesions in the liver or spleen, v) ileum
wall thickening > 4 mm or destructed ileum wall archi-
tecture)
Higher: Xpert MTB/RIF assay and/or bacteriolog-
ic culture (growth of M tuberculosis)
Lower: Positive Xpert MTB/RIF assay and/or
bacteriologic culture (growth of M tuberculosis)
OR acid-fast bacilli in sputum OR raised adeno-
Table 2.   Indext test threshold and reference standard of included studies 
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Ascites (any)
Hepatomegaly (not defined)
Lymphadenopathy (> 15 mm diameter)
Splenomegaly (not defined)
sine deaminase (ADA) levels in pleural, pericar-
dial or ascitic fluid OR negative microbiological
tests and improvement 2 months after start of
anti-tuberculosis treatment
O'Keefe 1998-h Ascites (any)
Lymphadenopathy (not defined)
Higher: Positive mycobacterial blood or bone
marrow cultures OR positive mycobacterial cul-
tures from 2 or more other sites OR post mortem
evidence
Sculier 2010-h Any abnormality (presence of ≥ 1: i) any lymph nodes ≥
12 mm, ii) ascites, iii) hepatomegaly, iv) splenomegaly,
v) hepatic or splenic hypoechoic lesions with or without
organ enlargement)
Higher: Positive culture for M tuberculosis from
any site




Lower: Positive bacteriological culture OR gran-
ulomatous inflammation with positive Ziehl-
Neelsen (ZN) staining on microscopy OR granu-
lomatous inflammation on microscopy OR visu-
al inspection on laparoscopy consistent with tu-
berculosis (presence of tubercles, fibro-adhesive
peritonitis, or caseating lymphadenopathy) and




Any abnormality (presence of ≥ 1: i) pericardial or pleur-




Lymphadenopathy (≥ 15 mm diameter)
Splenic lesions (multiple, hypoechoic, 2 mm to 5 mm di-
ameter)
Higher: Positive fluorescent microscopy, poly-
merase chain reaction, or tuberculosis culture
Lower: Microbiological confirmation (fluores-
cent microscopy, polymerase chain reaction,
culture) OR clinical diagnosis and anti-tubercu-
lous treatment initiated
Table 2.   Indext test threshold and reference standard of included studies  (Continued)


























5 879 (368) 63 (43 to 79) 68 (72 to 87) 35 to 82 20 to 92
Any abnormality (lower-qual-
ity reference standard)
4 397 (149) 68 (45 to 85) 73 (41 to 91) 37 to 88 22 to 92
Splenic lesions 6 916 (477) Not calculated Not calculated 13 to 62 86 to 100
Table 3.   Summary estimates of sensitivity and specificity for any abnormality and individual abdominal ultrasound
findings 
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Intra-abdominal lymph
nodes
8 917 (455) Not calculated Not calculated 22 to 86 56 to 100
Ascites 8 891 (433) Not calculated Not calculated 4 to 73 33 to 100
Splenomegaly 6 775 (397 Not calculated Not calculated 5 to 62 45 to 89
Hepatomegaly 4 373 (189) Not calculated Not calculated 24 to 76 20 to 78




A P P E N D I C E S
Appendix 1. Search strategy
Ovid MEDLINE® Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid MEDLINE® Daily and Ovid MEDLINE® <1946
to Present>
1 extrapulmonary tuberculosis.mp.
2 Peritonitis, Tuberculous/ or Tuberculosis, Gastrointestinal/ or Tuberculosis, Hepatic/
3 abdominal tuberculosis.mp.
4 Tuberculosis, Hepatic/ or liver tuberculosis.mp. or gastric tuberculosis.mp. or intestinal tuberculosis.mp.
5 Tuberculosis, Miliary/
6 disseminated tuberculosis.mp.
7 1 or 2 or 3 or 4 or 5 or 6
8 HIV infection.mp. or HIV Infections/
9 exp HIV/
10 human immunodeficiency virus.mp.
11 Acquired Immunodeficiency Syndrome/ or acquired immunodeficiency syndrome.mp.
12 (acquired immun* and deficiency syndrome).mp.
13 ((HIV* adj2 (people or person* or patient*)) or PLHIV).mp.
14 8 or 9 or 10 or 11 or 12 or 13
15 7 and 14
16 Radiography, Abdominal/
17 X-Ray DiIraction/ or x-ray*.mp.
18 (ultrasound or barium).mp.
19 Tomography, X-Ray Computed/
20 (comput* adj2 tomograph*).mp.
21 Magnetic Resonance Imaging/
22 (MRI or CAT).mp.
23 Ultrasonography/ or ultrasonograph*.mp.
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24 Bacteriological Techniques/ or Sputum/ or sputum specimen.mp.
25 liquid culture system.mp.
26 Xpert MTB*.mp.
27 Genotype MTBDR*.mp.
28 (lipoarabinomannan or LAM or LF-LAM).mp.
29 QuantiFERON-TB-Gold.mp. or Tuberculin Test/ or tuberculin.mp.
30 Diagnostic Imaging/ or Point-of-Care Systems/
31 (Laparotomy or laparoscopy or fine needle aspiration).mp.
32 CD4 Lymphocyte Count/
33 Ascites/diagnosis or Ascites/microbiology or Paracentesis/ or Laparoscopy/
34 colonoscopy.mp. or Colonoscopy/
35 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34
36 15 and 35
Embase 1947-Present, updated daily
--------------------------------------------------------------------------------
1 tuberculosis.mp. or tuberculosis/
2 (Abdominal or gastroenteric or gastrointestinal or intestinal or hepatic or liver or splenic).mp.
3 1 and 2
4 abdominal tuberculosis/
5 miliary tuberculosis/
6 HIV infection.mp. or Human immunodeficiency virus infection/
7 human immunodeficiency virus.mp.
8 acquired immune deficiency syndrome/
9 ((HIV* adj2 (people or person* or patient*)) or PLHIV).mp.
10 6 or 7 or 8 or 9
11 abdominal ultrasound.mp.
12 X ray/ or radiography/ or X ray*.mp.
13 (ultrasound or barium).mp.
14 (comput* adj2 tomograph*).mp.
15 Magnetic Resonance.mp. or nuclear magnetic resonance/
16 Ultrasonography.mp. or echography/
17 sputum analysis/ or sputum cytodiagnosis/ or sputum culture/
18 microbiological examination/
19 liquid culture/
20 (Xpert MTB* or Genotype MTBDR*).mp.
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21 (lipoarabinomannan or LAM or LF-LAM).mp.
22 (QuantiFERON-TB-Gold or Tuberculin Test).mp.
23 "point of care system"/
24 (Laparotomy or laparoscopy).mp
25 ascites fluid analysis/ or ascites/ or ascites fluid cytology/
26 colonoscopy/
27 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26
28 3 and 10 and 27
BIOSIS Previews
You searched for: TOPIC: ("liver tuberculosis" or "gastric tuberculosis" or "intestinal tuberculosis" or "abdominal tuberculosis".) AND
TOPIC: (HIV or AIDS or "acquired immunodeficiency syndrome") AND TOPIC: (ultrasound or ultrasonography or scan or "Magnetic
Resonance Imaging" or MRI or tomography)
Timespan: All years. Indexes: BIOSIS Previews.
Web of Science Core Collection
You searched for: TOPIC: ("liver tuberculosis" or "gastric tuberculosis" or "intestinal tuberculosis" or "abdominal tuberculosis") AND
TOPIC: (HIV or AIDS or "acquired immunodeficiency syndrome") AND TOPIC: (ultrasound or ultrasonography or scan or "Magnetic
Resonance Imaging" or MRI or tomography)
Timespan: All years. Indexes: SCI-EXPANDED, SSCI, CPCI-S, CPCI-SSH
ClinicalTrials.gov and WHO ICTRP
tuberculosis and ultrasound, tuberculosis and ultrasonography, tuberculosis and MRI
Appendix 2. QUADAS-2 tool tailored to the context of the review
 
Domain Patient selection Index test Reference standard Flow and timing
Descrip-
tion




was conducted and re-
ported
Describe patients that
did not receive and time
interval between index








Consecutive or random sam-
ple of patients?
• Yes if the study report-
ed consecutive enrolment
or random sampling of pa-
tients.
• No if patients were purpose-
fully selected, for example
based on previous test re-
sults (other tests or refer-
ence standard).
• Unclear if the study did not
explicitly state consecutive
enrolment or random sam-
pling, and it was unclear
how patients were sampled.
Index test results inter-
preted without knowl-
edge of the results of
reference standard?












Reference standard likely to
correctly classify the target
condition?
• Yes if the higher qual-
ity reference standard
was used (that is, cul-
ture, microscopic identi-
fication of acid-fast bacil-
li, or Xpert MTB/RIF).
• No if the lower quality
reference standard was
used (that is, not coupled
with any mentioned in
higher quality reference).
Was there an appropriate
interval between index
test and reference stan-
dard?
• Yes if abdominal ultra-
sound and the refer-
ence standard(s) (sam-
ples taken or clinical
diagnosis made) were
performed at the same
time or if the time in-
terval is less than one
week.
• No if the time period be-
tween ultrasound and
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• Unclear if insufficient in-
formation on the refer-
ence standard(s) used.
the reference standard
is more than one week.
• Unclear if insufficient or
no information on the
time interval.
Was a case-control design
avoided?
• Yes if a case-control design
was not used.
• No if patients with known
disease (cases) and pa-
tients without the disease
(controls) were clearly en-
rolled (such that partici-
pants are unrepresentative
of the spectrum of patients
seen in clinical practice).
• Unclear if the study design




edge of the results of index
test?
• Yes if results of the ref-
erence standard are in-
terpreted without knowl-
edge of ultrasound re-




• No if results of the refer-
ence standard were inter-
preted with knowledge of
ultrasound results
• Unclear if there is in-
sufficient information on





Did all patients receive a
reference standard?
• Yes if all participants re-
ceived a reference stan-
dard.
• No if one or more partic-
ipants did not receive a
reference standard.
• Unclear if there is insuf-
ficient information to
determine whether or
not all patients received
a reference standard.
Did all patients receive the
same reference standard?
• Yes if study participants
received the same refer-
ence standard (regard-
less of ultrasound re-
sult).
• No if participants did
not receive the same
reference standard.
• Unclear if there is insuf-
ficient information to
determine whether or
not all patients re-
ceived the same refer-
ence standard.
Did the study avoid inappro-
priate exclusions?
• Yes if no patients were ex-
cluded after inclusion in the
study.
• No if specific populations
were excluded (for example,
pregnant patients, elderly),
or patients with high CD4
counts were excluded be-
cause of low clinical suspi-
cion of TB.
• Unclear if unreported or in-
sufficient information given
to make a decision.
Pre-specified threshold
used?
• Yes if the study





10 mm in the short-
est diameter were
deemed as a positive
result”.
• No if multiple cut-oI
values were evaluat-
ed and an optimal




• Unclear if a cut-oI
was used but was not
reported, or only one
cut-oI value was re-
ported, but was not
explicitly pre-speci-
fied in the study.
Was incorporation bias
avoided (inclusion of index
test as part of the reference
standard)?
• Yes if abdominal ultra-
sound was not used as
part of the reference
standard.
• No if abdominal ultra-
sound formed part of the
reference standard.
• Unclear if insufficient in-
formation given to make
a decision.
Were all patients included
in the analysis?
• Yes if all participants re-
cruited into the study
were included in the
analysis.
  (Continued)
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• No if some participants
recruited into the study
were excluded in the
analysis.
• Unclear if unreported or
insufficient information






Could the selection of patients
have introduced bias?
Could the conduct or
interpretation of the
index test have intro-
duced bias?
Could the reference stan-
dard, its conduct, or its in-
terpretation has introduced
bias?








Are there concerns that the in-
cluded patients do not match
the review question?
• High if participants received
ultrasound in a tertiary care
(referral) centre or if asymp-
tomatic HIV-positive partici-
pants included.
• Low if participants received
ultrasound in any setting,
or if HIV-positive individuals
with presumptive abdomi-
nal tuberculosis or dissemi-
nated tuberculosis with ab-
dominal involvement in-
cluded.
• Unclear if insufficient infor-
mation to make a decision.
Are there concerns that
the index test, its con-
duct, or interpretation
differs from the review
question?




• Low if non-radiolo-
gists performed the
ultrasounds.
• Unclear if insufficient
information to make
a decision.
Are there concerns that the
target condition as defined
by the reference standard
does not match the review
question?
• High if studies did
not speciate mycobacte-
ria isolated in culture or
clinically diagnosed TB
cases were not followed
up to evaluate treatment
response.
• Low if studies did speci-
ate mycobacteria isolat-
ed in culture or clinical-
ly diagnosed TB cases im-
proved on anti-TB thera-
py.
• Unclear if insufficient in-






aGrading criteria for ‘Risk of bias' assessment
• If all signalling questions for a domain are answered ‘yes' then we will judge the risk of bias to be ‘low'.
• If any signalling question is answered ‘no' this will flag the potential for bias and we will judge risk of bias with a senior review author.
• If all signalling questions or most of them were answered ‘no', then we will judge the risk of bias as ‘high'.
• We will assign the ‘unclear' category when the study authors report insuIicient data to permit a judgment.
C O N T R I B U T I O N S   O F   A U T H O R S
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Meintjes. Eleanor A Ochodo analysed the data with input from Yemisi Takwoingi. Daniël J van Hoving and Eleanor A Ochodo interpreted the
analyses and draKed the manuscript. Graeme Meintjes, Gary Maartens and Yemisi Takwoingi provided critical revisions to the manuscript.
All review authors read and approved the final manuscript draK.
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D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
We amended the protocol title from Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with
abdominal involvement in HIV-positive adults to Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis
with abdominal involvement in HIV-positive individuals.
Our review diIered from the Cochrane protocol in several ways (Van Hoving 2017). In the protocol we stated a secondary objective to
determine the diagnostic accuracy of combinations of abdominal ultrasound and existing tests (chest radiograph, full blood count) for
detecting abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV-positive individuals. However, we
could not find any study that evaluated abdominal ultrasound as an add-on test or in combination with other tests, and we therefore did
not report on this.
The MEDION database is not active anymore and has not been searched.
In the protocol, we stated that we would have one primary meta-analysis at individual patient level. However we decided to have two
sets of primary meta-analyses; one with 2 x 2 tables generated with a higher-quality reference standard and the other with a lower-
quality reference standard. As stated in the analysis section, some studies produced two data points (with higher-quality and lower-quality
reference standards). Because we did not want to lose information by only selecting one data point for each study and also to produce
meaningful results, we present two sets of meta-analyses. We used Stata instead of SAS for all analyses.
Due to insuIicient data we did not investigate all potential sources of heterogeneity as stated in the protocol (including clinical setting,
and ultrasound training level).
We defined adults in the protocol as participants aged 18 years or older. Two studies included participants under 18 years (older than
15 years) (Sculier 2010-h; Weber 2018-h; Weber 2018-l). We included the studies as i) the number of paediatric cases was low, ii) many
countries manage 15-year-old patients as adults, and iii) the results would be valuable for policy making. However, we have downgraded
the certainty of the evidence for applicability concerns due to indirectness.
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We judged publication bias using three criteria: for-profit interest, only studies detected that produce precise estimates of high accuracy
despite small sample size, and knowledge about studies that were conducted but are not published.
I N D E X   T E R M S
Medical Subject Headings (MeSH)
AIDS-Related Opportunistic Infections  [*diagnostic imaging];  HIV Infections  [*complications];  Randomized Controlled Trials as Topic; 
Tuberculosis  [*diagnostic imaging];  Ultrasonography  [*methods]
MeSH check words
Humans
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